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ABSTRACT 
LIVER REGENERATION: POTENTIAL ROLES OF 
MESENCHYMAL STEM CELLS AND TOLL LIKE RECEPTORS 
Hande Koçak 
M.S. in Molecular Biology and Genetics 
Supervisors: Assist. Prof. Dr. K. Can Akçalı & Assoc. Prof. Dr. İhsan Gürsel 
August 2008, 89 Pages 
 
 
Liver has unique capacity to regenerate in response to loss of hepatocytes depending on 
viral infections, toxic reactions and cancer formation. Although liver regeneration have 
been extensively studied, factors participate in the process are still under extensive 
investigation. Differentiation and immunosuppressive potential, as well as homing 
capacity to the site of injury of mesenchymal stem cells (MSCs) can be harnessed in 
liver regeneration. Moreover, toll like receptors (TLRs) which are known to involve 
immuneregulatory mechanisms of MSCs may also be a player in this process. 
Therefore, in this study, our aim was to understand the possible roles of MSCs and 
TLRs during liver regeneration. First, TLR message distribution upon partial 
hepatectomy induction was assessed. Then, homing capacity of MSCs in liver 
regeneration was examined by injecting labeled MSC generated from normal or already 
PH initiated rats back into partially hepatectomized (PH) rats. After investigating MSC 
homing, mRNA expression profiles of several key TLRs in the course of liver 
regeneration with or without MSC administration was examined. Finally, the role of 
TLRs in immunoregulatory properties of MSCs was explored. Our data showed that 
MSCs from normal rats and at day 1 post PH are localized in liver of PH generated 
animals. We have also determined that injected MSCs increased TLR2, 3 and 9 
expressions in livers in comparison to that of hepatectomized liver that did not receive 
any MSC injection. Therefore, our data suggests that during liver regeneration at post 
PH day 3, homing of MSCs to the site of injury is at maximum and TLRs do not play 
any roles in recruiting these cells to liver, but rather localized MSCs either cis or at 
trans manner promote TLR expression. Despite the fact that MSCs are known to be 
non-immunogenic, in the present study isolated MSCs from BM are found to be 
expressing a panel of TLR mRNAs and our findings strongly implicate that these TLRs 
are functional in terms of cytokine secretion upon triggered by their proper ligands. 
Finally, we have identified that mouse MSC possesses different levels of critical surface 
markers such as CD11b, CD45, CD90 and CD117 at different passages and led us to 
think that either sub-populations or contaminating cell fractions may exist within the 
studied MSC population and furthermore may contribute to stimulatory potential of 
MSCs. 
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 ÖZET  
KARACİĞER REJENERASYONU: MEZENKİMAL KÖK HÜCRE 
VE TOLL BENZERİ RESEPTÖRLERİN POTANSİYEL ROLLERİ 
Hande Koçak 
Moleküler Biyoloji ve Genetik, Yüksek Lisans Tezi 
Danışmanlar: Yard. Doç. Dr. K. Can Akçalı ve Doç. Dr. İhsan Gürsel 
Ağustos 2008, 89 Sayfa 
 
Karaciğer, viral enfeksiyonlara toksik reaksiyonlara ve kanser oluşumuna bağlı olarak 
oluşan hepatosit kaybına cevap olarak kendini yenileyebilme kapasitesine sahiptir. 
Şimdiye kadar karaciğer rejenerasyonu geniş çapta çalışılmış olmasına rağmen, bu 
işleme katılan faktörler hala yoğun olarak çalışılmaktadır. Mezenkimal kök hücrelerin 
(MKH) farklılaşması ve immün baskılayıcı potansiyelleri kadar hasarlı bölgeye 
yönelme ve yerleşme kapasiteleri de onları karaciğer rejenerasyonunda önemli kılar. 
Ayrıca MKH’lerin bağışıklılığı düzenleme mekanizmalarına katılan toll benzeri 
reseptörler (TLR) de bu işlemde rol alıyor olabilirler. Bu çalışmadaki ana amacımız 
karaciğer rejenerasyonu esnasında MKH ve TLR’lerin iyileşme sürecine olası 
katkılarını araştırmaktır. Öncelikle, kısmi hepatektomi sonrasında TLR mesaj dağılımı 
belirlendi. Sonra, MKH’ların karaciğer rejenerasyonu esnasında hasarlı bölgeye 
yerleşme kapasiteleri kısmi hepatektomi (PH) yapılmış veya normal sıçanlardan alınan 
MKH’lerin işaretlenmesi sonrasında yine PH’lı sıçanlara geri verilmesiyle araştırıldı. 
Çalışmanın ileri evresinde, karaciğer rejenerasyonunda önemli olan bazı TLR’lerin 
mRNA ifade temelli profilleri ya sadece PH yapılmış ya da PH yapıldıktan sonra işaretli 
MKH enjekte edilmiş sıçanlarda araştırılmıştır. Son olarak, TLR’lerin, MKH’lerin 
bağışıklılığı düzenleyici özelliklerindeki rolleri araştırılmıştır. Sonuçlarımız normal ve 
bir günlük PH geçirmiş sıçanlardan alınan MKH’lerin, PH geçirmiş hayvanlara 
verildikten sonra o bölgeye yerleştiğini göstermektedir. Ayrıca PCR çalışmalarımız 
MKH enjeksiyonunun, MKH almamış PH geçirmiş karaciğerdekine göre TLR2, 3 ve 9 
gen mesaj ifadelerini arttırdığını saptadık. Bu nedenle, verilerimiz gösteriyor ki PH 3. 
gün sonrası karaciğer rejenerasyonu süresince, MKH’lerin yaralanma bölgesine 
yerleşmesi en yüksek seviyededir ve TLR’ler bu hücrelerin karaciğere çağırılmalarında 
rol oynamamaktadırlar. Bunun aksine enjekte edilmiş MKH’ler TLR ifadesini cis veya 
trans şekilde yönlendirmektedirler. MKH’lerin non-immünogenik olarak bilinmelerine 
rağmen, bu çalışmada kemik iliğinden izole edilen MKH’lerin birçok TLRı ifade 
ettikleri saptanmıştır ve bulgularımız bu TLR’lerin uygun ligandlarla uyarıldıklarında 
sitokin salgılanmasında fonksiyonel olduklarını göstermiştir. Son olarak, bu hücrelerin 
CD11b, CD45, CD90 ve CD117 gibi çok önemli yüzey belirteçlerine pasaj sayısına 
bağlı olarak farklı derecelerde değiştiğini saptadık ve bu bulgular kullandığımız MKH 
popülasyonunda ya alt grupların, ya da kontamine hücre gruplarının bulunduğunu 
düşündürmektedir. Belki de bu hücre grupları MKH’lerin uyarıcı özelliklerini 
yönlendirmektedirler.  
 
Anahtar Kelimeler: Mezenkimal kök hücre, karaciğer rejenerasyonu, toll benzeri reseptör
 
 
iv
  
 
 
 
 
 
 
 
 
 
 
 
TO MY PARENTS HATİCE, BASRİ YÜCEL 
AND MY SISTER EMİNE 
FOR THEIR UNCONDITIONAL LOVE AND SUPPORT 
 
 
 
 
 
 
 
 
 
v
ACKNOWLEDGEMENT 
 
First of all, I would like to thank and express my deepest gratitude to my supervisors 
Assist. Prof. Dr. Can Akçalı and Assoc. Prof. Dr. İhsan Gürsel for their guidance, 
encouragement, support, and patience throughout my thesis work. I would additionally thank 
them for their invaluable personal advices. 
I am very lucky to be a member of two groups with full of helpful and nice “lab” mates. 
I would like to thank my dearest friends Zeynep, Fatma, Gizem for their friendship, support and 
patience to my endless questions. I also would like to thank Sinan, Fuat, Rashad, Kutay, Tamer 
and Erdem for their friendship. 
I would like to thank Burcu for helping me in all my animal work. I could not have 
completed my thesis without her valuable assistance. 
I would like to thank Ceren, Şafak, Tolga, Elif, Bâlâ, Çiğdem, Serap, Aydan, Melda, 
Emre, Raşit who make me feel at home in Bilkent MBG as being excellent friends for me. 
I would like to thank Prof. Dr. Mehmet Uğur for his helps in fluorescence microscopy 
studies. 
 I would like to thank The Scientific and Technological Research Council of Turkey 
(TÜBİTAK) for their financial support throughout my thesis work. 
Finally, I would like to thank my dear family for trusting and encouraging me in my 
dreams to be a scientist. I would express my deepest love and appreciation to them for being 
always there for me. I would not find my way in life without their guidance. 
 
 
vi
TABLE OF CONTENTS 
 
SIGNATURE PAGE II
ABSTRACT III
ÖZET IV
DEDICATION PAGE V
ACKNOWLEDGEMENTS  VI
TABLE OF CONTENTS  VII
LIST OF TABLES  XI
LIST OF FIGURES  XII
ABBREVIATIONS XIII
1. INTRODUCTION  1
     1.1. Liver Regeneration  2
        1.1.1. Liver Regeneration During Normal Tissue Turnover  2
        1.1.2. Hepatocyte-Driven Regeneration after Partial Hepatectomy  3
           1.1.2.1. Mitogenic Signals Associated with Initiation of Liver 
Regeneration  
4
        1.1.3.  Progenitor Dependent Regeneration After Liver Injury   6
           1.1.3.1. Hepatic OvalCells 6
     1.2. Mesenchymal Stem Cells   7
     1.3. Immune System Responses  10
        1.3.1. Pathogen Recognition Receptors   10
        1.3.2. TLRs as Pattern-Recognition Receptors  10
           1.3.2.1. TLR1, 2 and 6 12
           1.3.2.2. TLR3 13
 
 
vii
           1.3.2.3. TLR4 13
           1.3.2.4. TLR 5 14
           1.3.2.5. TLR7, TLR8 14
           1.3.2.6. TLR 9 14
           1.3.2.7. TLR Signalling 15
              1.3.2.7.1. MyD88 Dependent Pathways 16
              1.3.2.7.1. MyD88 Independent Pathways 17
2.AIM OF STUDY  20
3. MATERIALS AND METHODS  21
     3.1. Animals  21
     3.2. Standard Solutions and Buffers  21
     3.3. Liver Regeneration Model  21
        3.3.1. Partial Hepatectomy and Sham Operations Alone 21
        3.3.2. Partial Hepatectomy Operation  21
        3.3.3. Sham Operations  23
     3.4. Cell Culture 23
        3.4.1. Cell Number Count with Thoma Cell Counter 23
        3.4.2. Spleen Cell Preparation 23
        3.4.3. Cell Distribution 24
        3.4.4. Stimulation with Different Toll Like Receptor Ligands 24
     3.5. RNA Isolation and Quantification  25
        3.5.1. Total RNA Isolation from The Liver Tissues  25
        3.5.2. Total RNA Isolation from Murine Splenocytes and Mesenchymal 
Stem Cells  
26
        3.5.3 Total RNA Isolation from Rat Mesenchymal Stem Cells 26
 
 
viii
        3.5.4 Quantification of RNA 27
             3.5.4.1. Denaturing Gel Electrophoresis 27
     3.6. The cDNA Synthesis  27
     3.7. RT-PCR Studies  28
        3.7.1. Conventional PCR    28
        3.7.2. Agarose Gel for Visualization of PCR Products  28
     3.8. The Real-Time RT-PCR Studies 29
     3.9. Administration of CM-DiI Labeled Mesenchymal Stem Cells to 
Partially Hepatectomized Rats  
31
        3.9.1. Chloromethylbenzamido-1,1–Dioctadecyl-3,3,3’,3’-Tetramethyl 
indocarbocyanine Perchlorate (CM-DiI; Lipophilic Carbocyanine) Labeling 
31
        3.9.2. Preparation of Labeled Mesenchymal Stem Cells For in vivo 
Injection 
31
        3.9.3. Administration of Labeled Mesenchymal Stem Cells to PH Rats 32
     3.10. Immunofluorescence Staining 32
     3.11. Fluorescence Microscopy Studies 33
     3.12. Isolation of the Bone Marrow From the Animals 33
     3.13. TLR Mediated Morphological Changes of MSC 34
     3.14.  Enzyme Linked-Immunoabsorbent Assay(ELISA) 34
        3.14.1 Cytokine ELISA 34
     3.15. Magnetic Bead Cell Separation 35
     3.16. Flow Cytometric Analysis of Cell Surface Markers 36
        3.16.1. Fixation of Cells 36
        3.16.2. Surface Marker Staining 36
        3.16.3. Flow Cytometric Analysis of Cells 36
     3.17. Statistical Analysis 37
 
 
ix
4. RESULTS 38
     4.1. MSC Homing in Partial Hepatectomized  Rats 38
        4.1.1. Administration of MSC from Normal Rat 38
        4.1.2. Administration of MSC from Hepatectomized Rats 40
        4.1.3. CD90 Expression in Hepatectomized Livers 40
        4.1.4. Flt3 Expression in Hepatectomized Livers 43
     4.2. Real Time RT-PCR Results  44
        4.2.1. TLR Expression in Partial Hepatectomized Rats 45
        4.2.2. Expression of TLRs in MSC-administered PH Groups 48
     4.3. Efforts to Delineate MSC Functions 53
        4.3.1.  TLR expression Pattern of Mesenchymal Stem Cells and Spleen 
Cells 
54
        4.3.2. Immunoregulatory Effects of Mesenchymal Stem Cells 55
        4.3.3. Bone Marrow Cell Separation Before MSC Generation 60
        4.3.4. MSC Characterization by Flow Cytometry 62
     4.4. TLR mediated Proliferation and Morphological Changes of Murine 
Mesenchymal Stem Cells 
64
5. DISCUSSION 66
6. FUTURE PERSPECTIVES 71
7. REFERENCES  72
8. APPENDICES 84
 
 
 
x
LIST OF TABLES 
Table 3.1 PCR reaction composition 28
Table 3.2 PCR running conditions 28
Table 3.3 The sequences and the sizes of the rat TLR primers used in this study 30
Table 3.4. Reaction composition for real-time PCR 31
Table 4.1 Efficiency values of primer sets used during real-time RT PCR 
studies 
45
Table 4.2 TLR2 Real time RT-PCR data for PH and MSC-administered PH 
groups 
49
Table 4.3 TLR3 Real time RT-PCR data for PH and MSC-administered PH 
groups 
49
Table 4.4 TLR9 Real time RT-PCR data for PH and MSC-administered PH 
groups 
50
Table 4.5. Product size of mouse TLRs and β-actin 55
Table 4.6. Expression of surface markers in different passages 63
 
 
   
 
 
xi
LIST OF FIGURES 
 
 
Figure 1.1. Time kinetics of DNA synthesis in different liver cell types during 
liver regeneration after partial hepatectomy   
4
Figure 1.2. Immunemodulating effects of ex-vivo expanded MSCs 9
Figure 1.3. TLR signaling activation by bacterial ligands 18
Figure 1.4. TLR signaling activation by viral PAMPs 19
Figure 3.1. The steps of the liver resection surgery for PH  22
Figure 3.2. The isolation of the bone marrow of the rats 33
Figure 4.1. Photomicrographs of Normal and PH Liver Sections that had 
labeled MSC generated from normal rat 
39
Figure 4.2. Photomicrograph of different liver sections that had labeled MSC 
generated  from 1d and 3day post PH rats 
41
Figure 4.3. Photomicrograph showing  CD90 expression in 3day post PH liver 
sections that received MSC generated from normal rat BM 
42
Figure 4.4. Photomicrograph showing  Flt3 expression in 3day post PH liver 
sections that received MSC generated from normal rat BM 
44
Figure 4.5. Fold change in TLR2, TLR3, TLR4, TLR5, TLR6, and TLR9 
expression in different time points (h) post PH 
46
Figure 4.6. Fold change in TLR2, TLR3 and TLR9 expression in PH and 
MSC-administered PH groups 
51
Figure 4.7. Variations in the TLR expression profile between mouse MSC and 
spleen cells 
55
Figure 4.8. IL6 production after 48h stimulation of different ratios of  MSC-
splenocyte co-culture with different TLR ligands 
56
Figure 4.9. IL6 production after 5days stimulation of CD34- and CD34+ cells 
with different TLR ligands 
61
Figure 4.10. Surface marker expression change of different MSC passages 63
Figure 4.11. TLR mediated Proliferation and Morphological Changes of 
Murine MSC 
65
 
 
 
xii
ABBREVIATIONS 
APC Antigen Presenting Cell 
bp Base Pairs 
BFB Bromophenol Blue 
BSA  Bovine Serum Albumin 
CD Cluster of differentiation 
cDNA Complementary Deoxyribonucleic Acid 
CFU-F Colony-forming Units-fibroblastic 
CYC Cyclophilin 
ddH2O Double Distilled Water 
DC Dendritic Cell 
DEPC Diethylpyrocarbonate 
dH2O  Distilled Water 
DMEM Dulbecco’s Modified Eagle Medium 
DNA  Deoxyribonucleic Acid 
DNase  Deoxyribonuclease 
dsRNA Double-stranded RNA 
EAE Experimental Autoimmune Encephalomyelitis 
EGF Epidermal Growth Factor 
ELISA Enzyme Linked-Immunosorbent Assay 
FACS Fluorescence Activated Cell Sorter 
FBS Fetal Bovine Serum 
FLT3 Fms-related Tyrosine Kinase 
g Grams 
GVHD Graft-versus-host Disease 
HGF Hepatocyte Growth Factor 
HSC  Hematopoietic Stem Cell 
HSCT Hematopoietic Stem Cell Transplantation 
ICAM Intercellular Adhesion Molecule 
IF Immunofluorescent 
IFN Interferon 
IKK IκB Kinase 
IκB Inhibitory of NFκB 
 
 
xiii
Ig Immunoglobulin 
IL Interleukin 
IRAK IL1R Associated Kinase 
IRF IFN- Regulatory Factor 
µg  Microgram 
µl  Microliter 
lt Liter 
LCT Liver Cell Transplantation 
LBP LPS-binding protein 
LPS Lipopolysaccharide 
LRR Leucine-rich-repeat 
LTA Lipoteichoic Acid 
Mac-1 Macrophage-1 antigen 
M  Molar 
MetOH Methyl Alcohol 
mg Milli Gram 
mL Milli Liter 
mM milliMolar 
MOPS 4-Morpholinopropanesulfonic Acid 
MS Multiple Sclerosis 
MSC Mesenchymal Stem Cell 
MyD88 Myeloid Differentiation Primary Response Gene 88 
NF-κB Nuclear Factor-kappa B 
NaCl Sodium Chloride 
NK Natural Killer 
NLR NOD-like Receptors 
NOD Nucleotide Binding Oligomerization Domain 
OD  Optical Density 
ODN Oligodeoxynucleotide 
OLT Orthotopic Liver Transplantation 
PAMP Pathogen associated molecular pattern 
PBS  Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
pDC Plasmacytoid Dendritic Cells 
 
 
xiv
PFA Paraformaldehyde 
PGN Peptidoglycan 
PH Partial Hepatectomy 
PI3K Phosphotidyl Inositol 3-Kinase 
pI:C Polyriboinosinic Polyribocytidylic Acid 
PNPP Para-nitrophenyl Pyro Phosphate 
PRR Pattern Recognition Receptor 
RIG-I Retinoic Acid-inducible Gene I 
RLH RIG-I-like helicase 
RNA  Ribonucleic Acid 
RPMI Roswell Park Memorial Institute 
RT Room Temperature 
RT-PCR  Reverse-Transcriptase Polymerase Chain Reaction 
RTK Receptor Tyrosine Kinase 
SA-AKP Streptavidin Alkaline-phosphatase 
SH Sham 
ssRNA Single Stranded RNA 
TAE Tris Acetate EDTA 
TGF Transforming Growth Factor 
TIR Toll/IL1 Receptor 
TIRAP Toll/IL1 receptor-associated Protein 
TLR Toll-like Receptor 
TNF Tumor Necrosis Factor 
TRAF TNF-associated Factor 
TRAM TRIF-related adaptor molecules 
TRIF TIR-domain containing adaptor inducing IFN-β 
XC  Xylene Cyanol 
 
 
 
 
xv
1. INTRODUCTION 
 
 Since the first development of the technique of orthotopic liver 
transplantation (OLT) in the early 1960s (Starzl et al, 1963), several improvements 
have been made in this field. Although OLT is considered as a gold standard 
treatment for liver failure, organ shortage problem leads researchers to study on 
alternative solutions. Despite having limiting factors as cell viability, modest 
engraftment and limited tissue viability (Philippe et al, 2008), liver cell 
transplantation (LCT) is one of the developing alternative with increasing success 
(Najimi and Sokal, 2005; Stephenne et al, 2006). Stem cells are very potent 
candidates for LCT due to their plasticity (Verfaillie, Pera and Landsdrop, 2002). 
Besides hematopoietic stem cells (HSCs) and adult liver stem/progenitor cells, 
mesenchymal stem cells (MSCs) are also used in liver cell therapy because of their 
hepatic potential (Philippe et al, 2008). 
 
In addition to their hepatic potential, MSCs have two other important 
properties that make them critical for LCT. One of them is their preferential 
migration into injured site, which results in targeting of the cells to the site of liver 
failure to a certain extent. The other one is their immunoregulatory properties. They 
are not only non-immunogenic but also immunosuppressive. Due to these features 
MSCs shine as a very promising tool for cell-based therapies including liver diseases.  
Being non-immunogenic is extremely important in every kind of transplantation 
providing a wide size of donor population.  
 
In recent decades, immunoregulatory properties of MSCs have been 
extensively studied. Although mechanism is unclear yet, there seems to be several 
factors playing role in immunoregulation. Pevsner-Fisher et al. (2007) has recently 
shown that murine MSCs express several Toll-like receptors (TLRs) and in particular 
TLR2 was found to be important in differentiation potential of MSCs. This leads us 
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to think whether there is a connection between TLRs and immunoregulatory property 
of MSC. 
 
In this context, firstly liver regeneration will be explained.  Then, next part 
will be about general characteristics and immunoregulatory properties of MSCs. In 
the last part, general characteristics and individual TLRs will be defined. 
 
1.1. Liver Regeneration 
 
Liver is an interesting organ with high regenerative capacity and complex 
functions (Michalopoulos and DeFrances, 1997; Taub, 2004). Liver regeneration has 
been an object of curiosity since the ancient Greeks recognized it in the myth of 
Prometheus. It is likely to be evolved to protect animals from the catastrophic results 
of liver loss caused by food toxins in nature (Fausto et al, 2006). It has also been 
shown that animals can survive surgical removal up to 75% of the total liver mass in 
experimental conditions (Bucher and Swaffield, 1964). 
 
Accumulating evidences has shown that there are at least three distinct liver 
regeneration mechanisms (Grompe and Finegold, 2001): 
 
1. liver regeneration during normal tissue turnover 
 
2. hepatocyte-driven regeneration after liver injury 
 
3. progenitor-dependent regeneration after liver injury 
 
1.1.1. Liver Regeneration During Normal Tissue Turnover 
 
The average life span of adult mammalian hepatocyte has been estimated to 
be around 200–300 days. One of the models regarding the mechanism of normal 
liver turnover is termed as “streaming liver”. Ponder (1996) suggested that the 
normal turnover in adult animals was proceeded primarily by in situ cell division of 
hepatocyte and not by stem cells. According to this model, young hepatocytes 
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emerge in portal zone and migrate toward central vein. In parallel to this model, 
differential gene expression patterns were seen in different zones of liver and this 
was explained by aging during the migration representing typical lineage 
progression. Moreover, ploidy and size of hepatocytes depend on the location within 
the lobule (Zajicek et al, 1985; Arber et al, 1988). However, there were other studies 
opposing “streaming liver” hypothesis. In 1985, Thurman and Kauffman showed that 
the difference in gene expression was due to the direction of blood flow. Thus, 
lobular zonation seems to depend on metabolite-induced gene regulation rather than 
lineage progression. Besides, hepatocyte migration during normal hepatocyte 
turnover was also opposed by retroviral marking studies (Bralet et al, 1994; Kennedy 
et al, 1995). These results were later confirmed in studies of hepatocyte growth 
pattern analysis in mosaic pattern of X inactivation in female mice (Shiojiri et al, 
1997, 2000).  
 
1.1.2. Hepatocyte-Driven Regeneration After Partial Hepatectomy 
 
Higgins and Anderson (1931) introduced the best experimental model with a 
precisely defined initiation of the regenerative stimulus, partial hepatectomy (PH), 
for the study of liver regeneration in response to liver injury. In partial hepatectomy, 
two-thirds of the liver is removed. Specific liver lobes are removed intact, without 
damage to the lobes left behind. Although the resected lobes never grow back, the 
residual lobes enlarge to compensate for the mass of the removed lobes in one week 
(Fausto et al, 2006). 
 
 The difference of liver regeneration from other regenerating tissues (bone 
marrow, skin) is that regeneration is not dependent on a small group of progenitor or 
stem cells except the case of large number of hepatocyte loss (see section 1.1.3). In 
order to rebuild the lost hepatic tissue, all the existing mature cellular populations in 
intact organ proceed liver regeneration by proliferating after PH. These include 
hepatocytes (the main functional cells of the organ), biliary epithelial cells (lining 
biliary ducts), fenestrated endothelial cells [a unique type of endothelial cells with 
large cytoplasmic gaps (fenestrae) that allow maximal contact between circulating 
blood and hepatocytes], Kupffer cells (macrophages in hepatic sinusoids) and cells of 
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Ito (satellite cells unique to the liver and located under the sinusoids; which surround 
hepatocytes with long processes, store vitamin A, synthesize connective tissue 
proteins, and secrete several growth factors ) (Michalopolus and DeFrances, 1997).  
 
Hepatocytes are the first to proliferate with a peak of DNA synthesis at 
around 24 hours (Figure 1.1.). The other cells of the liver enter into DNA synthesis 
about 24 hours after the hepatocytes and peak at 48 hours or later. After two to three 
days during PH, all cellular elements of the liver proliferate. Liver histology at day 
three to four after PH is characterized by clumps of small hepatocytes surrounding 
capillaries (Martinez-Hernandez and Amenta, 1995). By day 7, original number of 
cells is restored and hepatic histology consists of lobules that are larger in size prior 
to regeneration (Ogawa et al, 1979; Michalopolus and DeFrances, 1997). 
 
 
Figure 1.1. Time kinetics of DNA synthesis in different liver cell types during liver 
regeneration after partial hepatectomy. 
 
1.1.2.1. Mitogenic Signals Associated With Initiation of Liver Regeneration 
 
There are several factors affecting the induction of hepatocyte cell division. 
As indicated above, hepatocytes are the first cells of the liver to enter into the cell 
cycle and undergo proliferation, and they produce mitogenic signals for other hepatic 
cell types. Several studies have shown that mitogenic signals are present in the blood 
during liver regeneration. Initiation of liver regeneration may be attributed to that of 
mitogenic signals in a variety of mechanisms. 
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 Amongst these factors, Hepatocyte growth factor (HGF) and its receptor Met-
1 are key factors in liver growth and function (Naldini et al, 1991). HGF is 
responsible for the early events after PH. Several studies in humans have shown that 
plasma concentrations of HGF rise substantially when hepatic mass is decreased and 
plasma concentrations of HGF rise more than 20-fold within one hour after PH in 
rats (Michalopoulos et a., 1984; Tomiya et al, 1992, Lindroos et al, 1991). It is 
thought that PH confers stored HGF to be released by remodeling extracellular 
matrix and releases HGF which triggers hepatocytes to re-enter cell cycle through a 
signal transduction pathway (Bottaro et al, 1991).  
  
 Besides HGF, there are a variety of factors associated with liver regeneration 
both directly and indirectly. Most important ones are TNFα, IL6, EGF and TGFα. In 
deficiency of IL6 and TNFα receptor 1 (TNFR1), there seems slow and incomplete 
response following PH (Yamada et al, 1997, 1998; Yamada and Fausto, 1998). 
Although TNFα is not a direct mitogen for hepatocytes, its level increases after PH. 
TNFα was found to enhance the mitogenic effects of direct mitogens such as HGF, 
both in vitro and in vivo (Webber et al, 1998). IL6 also is not a direct mitogen for 
hepatocytes and does not enhance the mitogenic effect of other growth factors. 
However, it is a direct mitogen for biliary cells (Liu et al, 1998) and has important 
effects on integrity of the intrahepatic biliary tree by regulating production of small 
proline-rich proteins by cholangiocytes (Nozaki et al, 2005; Demetris et al, 2006). 
IL6 increases in the plasma following PH.  
 
Although plasma EGF concentrations rise only slightly after PH, EGF may 
play a mitogenic role in liver regeneration by quickly becoming more available to 
hepatocytes after PH.  
 
TGFα mRNA is induced in hepatocytes within 2 - 3 hours after PH, with a 
peak between 12 and 24 hours, and remains elevated for at least 48 hours after PH, 
and its over expression is shown to drive hepatocyte replication in vivo. 
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Termination of liver regeneration is also as important as initiation. However, 
compared to initiation mechanism, termination is less understood. It is found that a 
small wave of apoptosis in hepatocytes occurs at the end of regeneration (Sakamoto 
et al, 1999). Some studies suggest TGFβ as a potent terminating signal for liver 
regeneration (Jirtle et al, 1991). No other specific candidate for termination is known 
at this point, though potential ones can be predicted depending on their function in 
physiological conditions such as tumor suppressor genes. 
 
1.1.3. Progenitor Dependent Regeneration After Liver Injury 
 
1.1.3.1. Hepatic Oval Cells  
 
When there is a severe liver damage because of losing large number of 
hepatocyte and/or lack of their proliferation due to hepatoxins or carcinogens, liver 
utilizes a new source of cells to help repairing the liver. These small cells with high 
nucleus to cytoplasm ratio and ovoid shape are called hepatic “oval” cells. Oval cell 
proliferation is the result of progenitor-dependent regeneration since they are not 
derived from hepatocyte; rather they are associated with canals of Hering. However, 
the origins of oval cells are still debatable. Although most researchers tend to believe 
that the cells reside in the canals of Hering, it has been clearly indicated that at least a 
portion of the oval cells can be derived from bone marrow cells. In response to 
severe damage, these cells emerge in the portal zone, proliferate extensively and 
migrate into the lobule and eventually differentiate into hepatocytes (Farber, 1956; 
Shinozuka et al, 1978). These cells have the ability to proliferate-clonogenically and 
their bipotential capacity provides to differentiate into both hepatocytes and bile 
ductular cells (Oh et al, 2002). When hepatocytes do not respond to growth signals, 
oval cells are activated and proliferate rapidly as “facultative stem cells”. They 
initially appear near bile ductules and then migrate into the hepatic parenchyma. 
Oval cells were shown to change first into basophilic small hepatocytes and then 
differentiate into mature hepatocytes. There are several surface markers expressed on 
oval cells including hepatic markers and hematopoietic stem cell markers. Most 
commonly used markers are AFP, Thy-1, C-KIT, FLT3, CH18, CK19, GGT and 
OC2. 
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 In order to induce progenitor-dependent regeneration, in rat liver, the 
combination of 2-AAF treatment with either two-thirds partial hepatectomy (PH) or 
LD50 dose of carbon tetrachloride can be used. The continuous administration of low 
dose 2-AAF suppress proliferation of hepatocytes. Thus, hepatocytes of rats can not 
proliferate for regeneration after PH resulting in rapid proliferation of oval cells. 
  
1.2. Mesenchymal Stem Cells 
 
 Mesenchymal stem cells (MSCs) are adult stem cells constituting a rare 
population of non hematopoietic origin (0.01-0.001 % of total nucleated cells) in the 
adult bone marrow (Pitteger et al, 1999). They were identified during isolation of 
bone-forming progenitor cells from rat marrow by Friedenstein et al in 1966. They 
have the capacity to proliferate extensively and form colonies of fibroblastic cells 
which are defined as colony-forming units-fibroblastic; CFU-F (Friedenstein et al, 
1970). They differentiate into multiple mesenchymal lineage including adipocytes, 
osteoblasts, chondrocytes and myocytes (Pitteger et al, 1999) and cardiomyoctes in 
vitro (Makino et al, 1999). Besides mesenchymal lineage, it has been shown that 
they can differentiate along a number of endodermal and ectodermal tissues such as 
neurons (Woodbury, 2000), epithelial cells in skin, lung, intestine, kidney, spleen and 
liver (Chapel et al, 2003). To be able to differentiate into non-mesenchymal cell 
lineages demonstrate their plasticity and their potential in cellular therapies in several 
tissue repair and regeneration processes (Baksh et al, 2004). 
 
 One of the most challenging aspects of working with MSCs is the lack of 
specific cell surface markers for identification and characterization. They have 
common characteristics with other types of cells including endothelial and epithelial 
cells rather than displaying non-unique antigen profile. They express a number of  
different adhesion-related antigens, such as integrin subunits 4, 5, 1, integrins 
v 3 and v 5, ICAM-1, and CD44H (Conget and Minguell, 1999). Besides these 
nonspecific markers, there are some widely used cell surface antigens for in vitro 
characterization of MSCs, such as STRO-1 in human (Gronthos et al, 1994) and SH-
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2, SH-3, SH-4 (Baksh et al., 2004), CD71, CD90, CD106 and CD117 (Mangi et al, 
2003) in rodents. Despite this controversy about surface markers defining 
“mesenchymal stem cell”, there is a general agreement that the absence of CD34, 
CD45, CD31, Mac1 (CD11b), CD19 and glycophorin A expression distinguishes 
MSCs from hematopoietic cells, endothelial cells and endothelial progenitors (Deans 
and Moseley, 2000). 
 
 In recent decades, MSCs received increased interest due to their intrinsic self-
renewal capacity and ability to differentiate functional cell types in specific tissues. 
These properties provide MSC as a promising candidate for cell and gene therapies. 
There are several heartening therapeutical applications of MSCs including 
osteogenesis imperfecta (Horwitz et al, 1999), hematopoietic recovery (Koç et al., 
2000), bone tissue regeneration (Pettite et al, 2000), cardiovascular repair, spinal 
cord injury, coronary artery disease (Minguell, 2001) and in also several organ 
failures such as lung fibrosis in animal models (Matty, 2008). 
 
 Besides their involvement in tissue repair and regeneration, one of the most 
crucial characteristics of MSCs is their immunoregulatory property (Bartholomew et 
al, 2002; Inoue S. et al, 2006; Aggarwal and Pitteger, 2005). They can evade from 
immunerecognition (Rasmusson, 2006), therefore they are ideal carriers for gene 
delivery. In particular, generating stable clones with high efficiency with adenovirus-
mediated gene transfer make them popular in gene therapy (Baksh et al, 2004). 
Moreover, MSCs suppress immune responses (Rasmusson, 2006). Through multiple 
pathways, ex-vivo expanded MSCs have been shown to suppress a broad range of 
immune cells including T cells, B cells, NK cells and antigen presenting cells as 
shown in Figure 1.2. On the other hand, recent studies showed that MSCs have the 
dual ability to suppress and/or activate immune responses due to exposed stimulus 
(Stagg, 2007). 
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(Stagg, 2007) 
 
Figure 1.2. Immunemodulating effects of ex-vivo expanded MSCs. 
 
MSCs also suppress immune responses in vivo. Acute graft-versus-host 
disease (GVHD) is a common complication of allogeneic hematopoietic stem cell 
transplantation (HSCT) in which the immunocompetent cells in the graft reacts 
against host-derived antigens. After transplantation, mature T cells in the graft attack 
recipient tissue resulting in activation of host with secretion of proinflammatory 
cytokines including TNF-α and IL-1. In acute GVHD, donor T cells react to host 
APCs by activating donor T cells in a sequential manner. Since human MSC 
suppress the formation of cytotoxic T cells and alter the cytokine profile and 
maturation of antigen presenting cells, they may be used in potential cellular therapy 
in GVHD (Rasmusson, 2006). However, conflicting results have been reported 
regarding benefits of using MSC on GVHD. Among several studies, one of the most 
striking one showed that intravenous injection of MSC was found to be effective 
therapeutically in humans (Le Blanc et al, 2004). On the other hand, MSCs were 
found to be suppressing lymphocytes in vitro but have no effect on GVHD in mice 
(Sudres et al, 2006). MSCs are also used in autoimmune diseases. Experimental 
autoimmune encephalomyelitis (EAE), which is the “paradigmatic” model of 
multiple sclerosis (MS), is an autoimmune inflammatory disease of the central 
nervous system mediated by T cells and macrophages. Zappia E. et al (2005) 
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reported that intravenous injection of murine MSCs attenuated EAE by inducing 
tolerance of peripheral T cell against the pathogenic antigen. 
 
1.3. Immune System Responses 
 
 Immune system can be categorized into two distinct branches known as the 
“innate immunity” and the “adaptive immunity”. Adaptive immunity detects non-self 
through recognition of peptide antigens using antigen receptors expressed on the 
surface of B and T cells (Takeda et al, 2003) which is instructed by the innate 
immune arm. The initial immune response is mediated by the cells of the innate 
immunity that can recognize pathogens as well as altered self proteins expressed on 
host cells. One of the major and well studied receptor families of innate immunity is 
the toll like receptor family, which is a part of a broader group known as the 
pathogen recognition receptors. 
 
1.3.1. Pathogen Recognition Receptors 
 
Although the innate immune system lacks the fine specificity of adaptive 
immune system that is crucial for immunological memory, it can discriminate self 
from non-self. The basic machinery of innate immune recognition is highly 
conserved among species, from plants and fruit flies to higher mammals. Microbial 
pathogens possess specific molecular patterns called pathogen-associated molecular 
patterns (PAMPs). The host innate immune system recognizes these patterns with 
germ-line encoded pattern recognition receptors (PRRs) and elicits immune 
responses for eliminating pathogen and also activating adaptive immunity (Akira et 
al, 2001).  
 
Besides recognizing PAMPs which are crucial for survival of microorganism, 
there are several common characteristics of PRRs. First, they are expressed 
constitutively in the host. Second, PRRs are germ line encoded, nonclonal, expressed 
on all cells of a given type. Their expression is independent of immunologic 
memory. Different PRRs react with specific PAMPs and they can detect pathogens in 
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all stages of pathogen’s lifecycle. They show distinct expression patterns, activate 
specific signaling pathways, and lead to distinct anti-pathogen responses (Akira et 
al., 2006). 
 
Toll-like receptors (TLRs), which recognize a wide range of PAMPs 
including carbohydrates, lipids, proteins and nucleic acids, are well-known PRRs 
(Akira et al, 2006). Besides TLRs, there are two other important PPRs that play 
important roles in cytosolic recognition of invading pathogens: nucleotide binding 
oligomerization domain (NOD)-like receptors (NLRs) which have role in TLR-
independent activation of several signaling pathways and retinoic acid-inducible 
gene I (RIG-I)-like helicases (RLHs) which have role in antiviral responses (Kawai 
and Akira, 2006). I would like to focus only on TLRs for the scope of my thesis 
work. 
 
1.3.2. TLRs as Pattern-Recognition Receptors 
 
 TLRs are type I integral membrane glycoproteins that are characterized by the 
extracellular domains containing varying numbers of leucine-rich-repeat (LRR) 
motifs and a cytosolic signaling domain called the Toll/IL1R (interleukin 1 receptor) 
homology (TIR) domain which is homologous to the cytoplasmic signaling domain 
of IL-1 (Bowie and O’Neil, 2000). Toll, a receptor playing critical role in 
development of embryonic dorsoventral polarity and also antifungal response in 
Drosophila, is the first identified member of TLR family (Lemaitre et al, 1996). 
TLRs are also characterized by their evolutionary conservation from Caenorhabditis 
elegans to mammals (Roach et al, 2005; Akira et al, 2006).To date, 13 murine TLRs 
and 10 human TLRs have been identified (Kumagai et al, 2008). They have different 
ligand specificities and they presumably induce different target genes by same or 
different signaling pathways. 
 
 TLRs are expressed not only on various immune cells such as macrophages, 
dendritic cells (DCs), B cells, specific types of T cells but also on nonimmune cells 
including fibroblasts and epithelial cells (Kumagai et al, 2008). In addition, murine 
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MSCs have been shown recently to express several TLR molecules (Pervsner-
Fischer et al, 2007). In all cell types, expression of TLRs is modulated in response to 
pathogens, cytokines and environmental stress. While TLR1, 2, 4, 5 and 6 are 
expressed on the cell surface, TLR3, 7, 8 and 9 are found in intracellular 
compartments such as endosomes (Figure 1.3. and Figure 1.4.). Ligands of latter 
ones, mainly nucleic acids, are required to be internalized to endosomes for 
recognition. 
 
1.3.2.1. TLR1, 2 and 6 
 
One of the most extensively studied TLRs is TLR2. It recognizes  a wide 
range of microbial components including lipoproteins/lipopeptides from various 
pathogens, peptidoglycan (PGN) and lipoteichoic acid (LTA) from Gram-positive 
bacteria, lipoarabinomannan from mycobacteria, glycosylphosphatidylinositol 
anchors from Trypanosoma cruzi, a phenol-soluble modulin from Staphylococcus 
epidermis, zymosan from fungi and glycolipids from Treponema maltophilum 
(Takeda et al., 2003), LPS (lipoploysaccharide) preparation from non-enterobacteria 
such as Helicobacter pylori (Smith et al, 2003). 
 
 Although there is no certainty about mechanism of the wide spectrum of 
TLR2 recognition, it is thought that functional cooperation of TLR2 with several 
proteins accomplishes this task. For recognition of lipopeptide, TLR2 functions by 
forming heterodimers with structurally related TLRs such as TLR1 or TLR6. 
Forming heterodimers with either TLR6 or TLR1 may provide the recognition of 
diacyl or triacyl lipopeptides, respectively. This discrimination may be attributed to 
LRR domain topology, which is a unique property of TLR2 (Takeuchi et al, 2001; 
Takeuchi et al, 2002; Omueti et al, 2005). For recognition of fungal-derived 
components, TLR2 functions with members of the lectin receptor family, which may 
facilitate its activation by β-Glucan ligands (Gantner et al., 2003). In particular, C-
type lectin, Dectin-1, with ITAM motif in its intracellular domain, was found to 
interact with TLR2 to recognize yeast pathogens (Brown et al, 2003). 
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 The expression and activity of TLR2 was shown to be cooperatively regulated 
by pro-inflammatory molecules such as TNFα and anti-inflammatory molecules such 
as glucocorticoids (Hermoso et al, 2004). 
 
1.3.2.2. TLR3 
 
 TLR3 is also an important PRR in the host defense against viral infection. In 
life cycle of most viruses (in replication), double-stranded RNA (dsRNA) is 
produced and triggers antiviral and immunostimulatory activities by inducing 
synthesis of type I interferon (IFNα/β). It was found that expression of human TLR3 
in the dsRNA-non-responsive cell line 293 elicits activation of NF-κB in response to 
dsRNA. Moreover, TLR3 deficient mouse was found to lack antiviral activity in 
response to dsRNA (Alexopoulou et al, 2001). These showed that TLR3 has a major 
role in the recognition of dsRNA (Takeda et al, 2005). TLR3 is known to be 
expressed by dendritic cells (DCs), macrophages, and epithelial cells. Moreover NK 
cells were found to respond to polyriboinosinic polyribocytidylic acid (polyI: C; 
synthetic dsRNA) through production of proinflammatory cytokines, including IL6 
and IL-8, as well as the antiviral cytokine IFN-γ (Schmidt, 2004). 
 
1.3.2.3. TLR4 
 
 In last decade, importance of TLR4 in LPS (major component of the outer 
membrane of Gram-negative bacteria) recognition was demonstrated with the studies 
showing that TLR4 point mutation causes LPS hyposensitivity in mice (Poltorak et 
al, 1998; Hoshino et al, 1999). Similar to TLR2, TLR4 respond not only to LPS but 
also other molecules such as taxol derived from Taxus brevifolia (Kawasaki et al, 
2000) and respiratory syncytial virus fusion protein (Kurt-Jones et al, 2000). In 
addition, TLR4 has been shown to be activated by very high concentrations of 
endogenous ligands, such as heat shock proteins (HSP60 and HSP70), extra domain 
A of fibronectin, oligosaccharides of hyaluronic acid, heparan sulfate and fibrinogen 
(Takeda and Akira, 2005). 
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 LPS recognition by TLR4 requires several accessory molecules. LPS-binding 
protein (LBP) is a serum protein to which LPS is bound. It transfers LPS monomers 
to CD14 (Wright, 1989). CD14 which can be either secreted to serum or expressed as 
membrane-associated glycosylphosphatidyl inositol-linked protein at the surface of 
cells (especially in peripheral blood monocytes and macrophages) is a co-receptor of 
TLR4. After binding to CD14, LPS comes in close proximity with TLR4. Besides, 
MD-2 is another component of receptor complex (Shimazu, 1999). 
 
1.3.2.4. TLR5  
 
TLR5 recognizes flagellin subunits of flagellum, which is a complex structure 
required for bacterial motility (Smith et al, 2003). These flagellin subunits induce 
inflammatory mediators, such as TNFα and IL-8 in epithelial cells (Eaves-pyles et al, 
2001). Moreover, it was found that flagellin signaling is abrogated by the TLR5 
allele polymorphism 392STOP and it has been associated with Legionella 
pneumophila pneumonia (Hawn et al, 2003). 
 
1.3.2.5. TLR7, TLR8  
 
 TLR7 and TLR8 are structurally highly conserved proteins, and recognize 
same ligands in some cases. Both TLRs are expressed in mice but mouse TLR8 
appears to be non functional (Akira et al, 2006). TLR7 is highly expressed in 
plasmacytoid dendritic cells. These cells produce IFN type I (α/β IFN) in response to 
viral infection. TLR7 and TLR8 recognize viral and nonviral single stranded RNA 
(ssRNA) and activate cytokine production through interferon regulatory pathway; 
IRF3 and IRF7 (Kawai et al, 2004; Ito et al, 2005). TLR7 and human TLR8 was 
found to recognize guanidine- or uridine-rich ssRNA from viruses including human 
immunodeficiency virus (Heil et al, 2004), vesicular stomatitis and influenza virus 
(Lund et al., 2004; Diebold et al, 2004). Moreover, imidazoquinoline (R848), which 
is crucial in treatment of genital warts, is also recognized by human TLR7 and TLR8 
(Hemmi et al, 2002).  
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1.3.2.6. TLR9 
 
 CpG dinucleotides have recently gained attention because of their 
immunostimulatory properties. Although bacterial DNA contains several 
unmethylated CpG motifs, the frequency of CpG motifs decreases significantly in 
vertebrates. In addition to reduction in terms of quantity, cystein residues of CpG 
motifs are highly methylated in vertebrate. Methylation in vertebrates leads 
impairment of immunostimulatory effect of CpG (Krieg et al, 1995). TLR9 was 
found to be responsible for unmethylated CpG recognition in TLR9-deficient mice 
studies (Hemmi et al, 2000). It is primarily expressed on B cells, NK cells and DCs 
in the course of proliferation, maturation and cytokine, chemokine of 
immunoglobulin (Ig) secretion (Krieg, 2000). There are at least two types of CpG 
DNA which differentially activate plasmacytoid dendritic cells (pDC) versus B cells. 
First identified, conventional CpG is B/K- type CpG. It is made up of 
phosphorothioate backbone and it has more than one CpG motifs on a single 
backbone with no poly (G) tail. The other one, A/D- type CpG, is structurally 
different from conventional CpG in terms of having 
phosphodiester/phosphorothioate mixed backbone. It has a single palindromic 
sequence outside the CpG motif linked to a poly (G) tail at the 3’ and 5’ ends. B/K- 
type CpG can induce inflammatory cytokines including IL12 and TNFα and B cell 
proliferation. On the other hand, A/D-type CpG induce IFNα from pDC, but it has 
less ability to induce IL-12 and fails to stimulate B cells (Gursel et al, 2002; 
Verthelyi et al, 2001). Although TLR9 has found to be essential for recognition of 
both types of CpG (Hemmi, 2003), difference of these CpG-ODNs in terms of 
cellular specificity and functional effects are still under question. However, 
CXCL16, a co-receptor expressed on human pDC but not B cells, can be possible 
explanation for these differences since it selectively recognizes and mediates the 
subcellular localization of D ODN (Gursel et al, 2006). Besides bacterial CpG, virus-
derived CpG, such as murine cytomegalovirus in PDC has been found to be 
recognized by TLR9 (Krug et al, 2004). Moreover, TLR9 appears to be involved in 
the pathogenesis of autoimmune disorders, such as systemic lupus erythematosus 
through chromatin structure recognition (Takeda and Akira, 2005). 
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1.3.2.7. TLR Signaling  
 
 Expressions of several genes that are involved in immune response are 
triggered by stimulation of TLRs by microbial components. Molecular mechanisms 
underlying induction of these genes through TLR signaling pathways are now being 
rapidly elucidated (Akira and Takeda, 2004). Microbial recognition of TLRs 
facilitates dimerization of TLRs either homo-or heterodimers similar to TLR2-TLR1 
or TLR2-TLR6 heterodimers (Saito, 2004). TLR dimerization triggers activation of 
signaling pathway through their cytoplasmic TIR domain. A TIR domain-containing 
adaptor protein, particularly, MyD88, associates with TIR domain of receptor and 
provide induction of several pro-inflammatory cytokines such as TNFα and IL12 
(Hemmi et al, 2002; Takeuchi et al, 2000). Activation of different TLRs leads to 
different pattern of gene expression through individual TLR signaling cascades, 
although MyD88 is common to all. However, there are also MyD88 independent 
pathways as well as MyD88 dependent pathways. 
 
1.3.2.7.1. MyD88 Dependent Pathways  
  
 In almost all TLR signaling pathways, there is an adaptor molecule forming 
a complex with TIR domain to initiate signaling events. MyD88 functions as such for 
innate response activation. It has been shown  that MyD88-deficient mice do not 
produce inflammatory cytokines including TNF-α and IL12p40 in response to all 
TLR ligands (Takeuchi et al, 2000; Kawai et al, 1999; Schnare et al, 2000). 
Therefore, MyD88 is essential for inflammatory cytokine production through all 
TLRs. 
 
 MyD88 has a TIR domain, through which it associates with TLRs, on its C- 
terminal portion between residues 155-296 (Hultmark, 1994). Besides, it has a death 
domain (DD) in its N-terminal that confers association with other DD-containing 
proteins (Boldin et al, 1995). This domain is found to be important for TLR-induced 
cell death (Aliprantis et al, 1999). MyD88 has also an intermediate domain (ID) that 
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is essential for TLR signaling in terms of interacting with IL1R associated kinases 
(IRAKs) (Arancibia et al, 2007). 
 
 Upon stimulation (Figure 1.3. and Figure 1.4.), MyD88 recruits IRAK4 to 
TLRs through interaction between their DD and this facilitates IRAK-4 mediated 
phosphorylation of IRAK-1. Activated IRAK1 associates with TRAF6 leading to 
activation of two distinct signaling pathways. In the first one, AP-1 transcription 
factors are activated through activation of MAP kinases. In the second one, 
TAK/TAB complex, which enhances the activity of IκB kinase (IKK) complex, is 
activated. Then the IKK complex induces phosphorylation and subsequent 
degradation of IκB leading to nuclear localization of transcription factor NF-κB 
(Takeda and Akira, 2005) 
   
1.3.2.7.2. MyD88 Independent Pathways 
 
 In MyD88-deficient macrophages, despite the lack of TLR-4 induced 
production of proinflammatory cytokines, NF-κB activation is seen with delayed 
kinetics (Kawai, 1999). This indicates that although proinflammatory cytokine 
production is completely MyD-88 dependent, but yet there is a MyD88 independent 
component leading to the activation of NF-κB in TLR4 signaling. Furthermore later 
it has been shown that transcription factor IRF-3 is also activated in response to 
TLR4 stimulation in a MyD88-independent manner (Kawai, 2001). TLR4-induced 
activation of IRF3 leads IFN-β production which activates Stat1 and results in the 
induction of several IFN-inducible genes (Toshchakov et al, 2002; Hoshino et al., 
2002; Doyle et al, 2002). Viral infection or dsRNA was also found to activate IRF-3 
(Yoneyama et al, 1998). Thus, TLR3 and TLR4 utilize the MyD88-independent 
pathways to induce IFN- β (Figure 1.3. and Figure 1.4.). TLR3 and TLR4 expressed 
on APCs require the TIR-domain containing adaptor inducing IFN- β (TRIF) protein 
for the induction of NF-κB activation (Brint et al, 2002). 
 
 TLR4 activation by LPS may induce the expression of the TRIF-related 
adaptor molecule (TRAM/TICAM-2) and TRAM binds to both TLR4 and TRIF. 
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TLR4 utilizes TRIF and TRAM independently of other adaptor molecules, such as 
MyD88, to initiate late phase of NF-κB activation. It also induces the expression of 
IFN-β and other IFN-inducible genes via IRF-3 (Brint et al, 2004; Oshiuma et al, 
2003, Figure 1.3.). TRAM is indispensably required for bridging TRIF and TLR4 in 
TLR4 mediated responses. TRAM-/- mice are completely impaired in their response 
to LPS, while response was seen in My88 deficient mice with delayed kinetics 
(Horng et al, 2002; Yamamoto et al, 2002). 
 
 
 
                       Arancibia et al, 2007 
  
Figure 1. 3. TLR signaling activation by bacterial ligands 
 
In response to TLR3 signaling activation by viral dsRNA, TRIF is recruited 
to the receptor and induces IFN type I through TRIF-IKK-ζ (Figure 1.4.). In addition, 
agonist activation of TLR3 may promote tyrosine phosphorylation leading 
phosphotidyl inositol 3-kinase (PI3K) recruitment, Akt activation and eventually 
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IRF-3 phosphorylation (Sarkar et al, 2004). TLR3 can also stimulate pro-
inflammatory cytokine expression through connecting the TRIF downstream 
signaling molecule to activation of NF-κB (Meylan et al, 2004). 
 
 
 
                      Arancibia et al, 2007 
  
                         Figure 1.4. TLR signaling activation by viral PAMPs 
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2. AIM OF STUDY 
 
  Liver transplantation is a well accepted treatment option for end-stage liver 
disease and acute liver failure. However, due to the donor shortage, new therapy 
strategies are becoming more important than ever. Amongst them liver cell 
transplantation (LCT) has been receiving great attention in recent years due to the 
improvement on the isolation and expansion of hepatocyte and stem/progenitor cells. 
In this context, MSCs are also important candidates as a source of cell due to their 
distinctive characteristics such as hepatic differentiation potential, homing to the site 
of injury and nonimmunogenicity.  
 
  By using a well established liver regeneration model of partial hepatectomy in 
rats, we aimed to investigate the followings in this thesis; 
 
i) The effect of liver regeneration on the homing mechanisms of MSCs.  
 
ii) Potential roles of MSCs and TLRs during liver regeneration. 
 
    iii)    Role of TLRs expression on MSCs and their contribution to the 
immunoregulatory function of MSCs 
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3. MATERIALS AND METHODS 
 
3.1. Animals  
 
Adult male Spraque Dawley rats (7-9 months old) and adult male BALB/c 
mice (8-12 weeks old) were used for the entire study. The animals were kept in the 
animal holding facility of the Department of Molecular Biology and Genetics at 
Bilkent University under controlled ambient conditions (22o C ± 2) with 12 hour light 
and 12 hour dark cycles. They were provided with unlimited access of food and 
water. The experimental procedures have been approved by the animal ethical 
committee of Bilkent University (Protocol No: Bil-AEC 2005/2). 
 
3.2 Standard Solutions and Buffers 
 
For details of the solutions and buffers used for several assays, please refer to 
Appendix A section. 
 
3.3. Liver Regeneration Model 
 
3.3.1. Partial Hepatectomy and Sham Operations Alone 
 
 In this study, 7-9 months old male Sprague-Dawley rats were used. Partial 
hepatectomy procedure was standardized by Higgins and Anderson (1931). 
 
3.3.2. Partial Hepatectomy Operation 
 
The rats were pre-anesthetized firstly with ether chamber and then 
anesthetized with ketalar (2, 5-2, 8 mL/g) by intraperitonal injection. They were 
immobilized on the operation stand. Under aseptic conditions, the skin was cut and 
the abdomen was opened by cutting the peritoneal membrane through the midline (in 
Figure 3. 1.). 
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 Figure 3.1. The steps of the liver resection surgery for partial hepatectomy (PH)  
 
 
 After opening of the abdomen, ligaments connecting liver to diaphragm and 
connecting the lobes of the liver was cut. The middle lobe (40% of total liver mass) 
and the front lobe (30% of total liver mass) were removed after the branches of vena 
cava inferior entering these lobes was tied with silk suture. The removed lobes were 
immediately washed with PBS and snap frozen in liquid nitrogen for further storage. 
The specimens (approximately 70% of the original liver) were stored in -80 oC until 
further use. 
 
After removing the lobes, 10 mL of NaCl is injected into abdominal cavity to 
compensate dehydration. Then, the abdomen was sutured, and left in cages (one 
animal per cage); the cages were warmed and watched until the animals were 
conscious again. 
 
For mRNA expression experiments, the animals (2 per time points) were 
sacrificed 2, 4, 12, 18, 24 hours after PH. Their livers were removed and washed 
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with PBS and were snap frozen in liquid nitrogen. The specimens were stored in -80 
oC for further use. 
  
3.3.3. Sham Operations 
 
The surgical operations in sham group of rats were performed similar to PH 
operations (for details see Section 3.3.2.), but the exception in the procedure was that 
the livers of these animals (2 animals per time point as specified in previous section) 
were not removed. 
 
3.4. Cell Culture 
 
3.4.1. Cell Number Count With Thoma Cell Counter  
                    
After the heterogeneous bone marrow cells was washed and precipitated, they 
were suspended in 10 mL of MesenCult® (StemCell Technologies) media and the 
mixture was micropipetted into a hemocytometer.  
 
The total number of cells in the chamber was determined by counting the 
cells under the light microscope from the four gridlines. The cell number was 
calculated according to the following formula: 
 
                               Cell Number      106   = Total cell number in 10 mL media 
                                       4         
 
3.4.2. Spleen Cell Preparation 
 
Spleens were removed from the BALB/c male mice after cervical dislocation. 
In order to obtain single cell suspensions, the spleens were smashed with the back of 
a sterile syringe by circular movements and suspended in 2% FBS supplemented 
regular RPMI media. The cells were washed 3 times with media at 1500 rpm for 10 
minutes. After removal of the cell debris, the cell pellet was gently dislodged with 
fresh media. The splenocyte suspension was counted as indicated in section 3.4.1. 
 
 23
 3.4.3. Cell Distribution 
 
For MSC and splenocyte interaction assays splenocytes were distributed into 
96 well plates with a final cell number of 105 cells per well. Then MSCs were titrated 
on the splenocytes with a ratio of 1:1 to 1: 105 (MSC to splenocyte) in triplicate. 
Splenocyte alone (105cells per well) and MSC alone (105 cells per well) sets were 
also layered in triplicates as separate groups. 
 
After magnetic bead separation cells, CD34- and CD34+ cells  were 
distributed into 96 well plates with a final cell number of 105 cells per well. 
Stimulations were done in triple wells. 
 
For TLR mediated morphological changes of mouse mesenchymal stem cells, 
the cell number was adjusted to 106 cells/well in 6 well plates. The ligands were 
replenished every three days for the duration of assay. 
 
3.4.4. Stimulation With Different Toll like Receptor Ligands 
 
Co-cultured splenocytes and MSCs were stimulated with TLR ligands (i) 
PGN (TLR2L or TLR2/6L); 5µg/mL, (ii) pI:C (TLR3L); 20µg/mL, (iii) LPS 
(TLR4L); 5µg/mL, (iv) R848 (TLR7/8L); 5µg/mL, (v) CpG DNA (TLR9L) 
ODN1555 a 15 mer ODN or ODN K23 a 12 mer ODN) ; 1µM, and (vi) Control 
ODNs (ODN1612 or ODN K23CGflip ODN); 1µM. Supernatants were collected 36 
to 42 hours after stimulation. 
 
CD34- and CD34+ cells were also stimulated with above indicated TLR 
ligands with different concentrations ((i) PGN; 1µg/mL, (ii) pI: C; 10µg/mL, (iii) 
LPS; 10µg/mL, (iv) CpG ODN1555; 1µM, and (v) Control ODN1612; 1µM). 
Supernatants were collected 5 days after stimulation. For TLR mediated 
morphological changes, mesenchymal stem cells were stimulated with TLR ligands 
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for 12 days (in every 3rd day the ligands were replenished). Similar concentrations 
were used as for CD34 cells.  
 
Cells were cultured with 5% oligo FBS supplemented RPMI 1640 or DMEM 
media when they were stimulated with ODNs or dsRNA and were cultured with 5% 
regular FBS supplemented RPMI-1640 or DMEM when they were stimulated with 
other ligands. 
 
3.5. RNA Isolation and Quantification 
 
3.5.1. Total RNA Isolation From The Liver Tissues  
 
All solutions and materials were prepared/treated with diethylpyrocarbonate 
(DEPC, Sigma) in order to avoid RNase contamination. Throughout the isolation 
process the centrifugations were conducted at 4oC. The total RNAs were isolated by 
using TriPure solution (Roche/Boehringer Mannheim, Indiana, USA) according to 
the manufacturer’s protocol. 100 mg of tissue sample was homogenized in 1 mL of 
TriPure solution by using the homogenizer. Then the homogenate was incubated for 
5 minutes at room temperature (RT), and allowed complete dissociation of the 
nucleoprotein complexes. Afterwards, 0.2 mL of chloroform was added and the tube 
was shaken vigorously for 15 seconds. After incubation at RT for 15 minutes, the 
tube was centrifuged at 12000Xg for 15 minutes resulting in three distinct phases. 
The colorless upper part was transferred to a new eppendorf and 1mL isopropanol 
was added on the sample and immediately mixed gently by inverting the tube few 
times and left at RT for 10 minutes. After centrifugation at 12000Xg for 10 minutes 
the supernatant was discarded. The pellet was washed with 75% ethanol, and then 
centrifuged at 12000Xg for 5 minutes. The supernatant was discarded and pellet was 
air-dried on bench for about 10-15 minutes. The RNA pellets were resuspended in 
100 µl of the DEPC-treated ddH2O. 
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3.5.2. Total RNA Isolation From Murine Splenocytes and Mesenchymal Stem 
Cells  
 
The total RNAs form murine mesenchymal stem cells (for details, please see 
Section 3.10.) and murine splenocytes were isolated using TriZol® reagent 
(Invitrogen, USA) according to the manufacturer’s protocol. Adherent fraction of 
mouse MSCs were pooled (centrifuged at 1500 rpm for 5 minutes) following 
trypsinazation. Low Glucose DMEM (supplemented with 10 % FBS) was added to 
the trypsinized cells during centrifugation and the media was removed. The cell 
pellet was washed once with PBS and centrifuged again at the same setting. The cells 
were counted on hemocytometer. Afterwards, 1 mL of TriZol® was added onto per 
107 cells and dislodged by 10-15 times successive mild pipetting. After incubating 
the cells in TriZol® for 15 minutes at RT, 0.2 mL of chloroform/mL of TriZol® was 
added to the cells and vigorously shaken for 15 seconds. The mixture was incubated 
for 5 minutes at RT and centrifuged at 1200Xg for 15 minutes at 4oC. Following 
centrifugation, the upper aqueous transparent fraction which contains total RNA was 
transferred into a new tube and 0.5 mL of isopropanol per 1 mL of TriZol® reagent 
was added and the tube was incubated for another 10 minutes at RT, the samples 
were centrifuged at 12000Xg for 10 minutes. The supernatant removed and the pellet 
was washed with 1 mL of 75 % ethanol per 1 mL of TriZol® reagent used. The 
samples were gently vortexed and centrifuged at 7500Xg for 5 minutes at 4oC. The 
supernatants were discarded and pellets were air-dried under laminar flow hood. The 
RNA pellets were resuspended in 20-30 µl of DEPC-treated water. 
 
3.5.3. Total RNA Isolation From Rat Mesenchymal Stem Cells 
 
 On the 14th days of the cell culture, total RNAs from the MSCs were isolated. 
The cells were first washed with 1X PBS buffer in order to eliminate the non-
adherent cells in the media. Then the cells were trypsinized and incubated at 37oC for 
5 minutes. MesenCult® (StemCell Technologies) media was added to the trypsinized 
cells and centrifuged at 1500 rpm for 5 minutes. Then the media was removed and 
the precipitated cells were washed with cold PBS buffer and centrifuged again at 
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1500 rpm for 5 minutes. Next, the buffer was removed and the total RNA was 
isolated from the precipitate by using RNeasy Mini Kit (Qiagen, Germany) 
according to the manufacturer’s protocol. The RNA isolated from several sources 
was stored at -80oC for further use.    
 
3.5.4. Quantification of RNA 
 
The concentrations of RNA samples were measured via NanoDrop® ND-
1000 (Nano Drop Technologies, USA) and the quality of RNAs was determined by 
measuring the ratio of A260/A280. The OD260/OD280 ratios were calculated in order to 
determine if there is a phenol, protein or DNA contamination in the RNA samples. 
The acceptable ratio was expected to be from 1.6 to 2.0. In order to check the 
integrity of the isolated RNAs denaturing agarose gel electrophoresis was performed. 
  
3.5.4.1. Denaturing Gel Electrophoresis 
 
In order to check the integrity of the isolated RNA denaturing agarose gel 
electrophoresis was performed for all samples. 1.2 % denaturing agarose gel was 
prepared with DEPC-treated water, including 10X MOPS, 3.6 % formaldehyde and 
30 ng/mL ethidium bromide solution. The electrophoresis tank contained 1X MOPS 
during running the gels. The samples were prepared by addition of 2 µl agarose gel 
loading dye, 3 µl RNA and 3 µl DEPC-treated H2O. The samples were incubated at 
65ºC for 15 minutes in order to allow RNA denaturation. The gel was run at 90V, for 
45 minutes and visualized under transilluminator (Gel-Doc BIO-RAD, USA or 
Vilber Lourmat, France). Chemicapture (Vilber Lourmat, France) software was used 
to take photographs of the gels. 
 
3.6. The cDNA Synthesis 
 
The cDNA was synthesized from the extracted total RNA sample using a 
cDNA synthesis kit (Finnzymes, Finland) according to the manufacturer’s protocol. 
2 µg RNA was mixed with 1.5 µl of Oligo (dT) primer and completed to a total 
volume of 14µl with DEPC-treated water. They were pre-denaturated at 65ºC for 5 
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minutes and incubated on ice for 3-5 minutes. 20 µl 2X RT buffer (includes dNTP 
mix and 10 mM MgCl2). Then a 4 µl M-MuLV RNase H reverse transcriptase 
including RNase inhibitors were added to the mixture and incubated at 25ºC for 10 
minutes, 40ºC for 45 minutes, 85ºC for 5 minutes, and on ice for 10 minutes, 
respectively. The cDNAs were stored at -20ºC for further use.  
 
3.7. RT-PCR Studies 
 
3.7.1. Conventional PCR 
  
The reaction ingredients used in PCR reactions are shown in Table 3.1. and 
the condition of PCR reactions are shown in Table 3.2.  
 
Table 3. 1. PCR reaction composition 
 
  
Reaction Ingredients Volume 
cDNA  1.5 µl 
2X DyNAyzme II Master Mix (Finnzymes) 12.5 µl  
Forward Primer  (from 10 pmol stock) (Alpha DNA) 1 µl  
Reverse Primer  (from 10 pmol stock) (Alpha DNA) 1 µl  
DNase RNase free H2O (HyClone) 9 µl 
Total 25 µl 
Table 3.2 PCR running conditions  
 
 
 
 
 
 
30 sec @ 94oC 
 30 sec @ 55oC                    35 cycles 
 1 min @ 72oC 
  
     Final Extension: 10 minutes @ 72oC 
 
3.7.2. Agarose Gel For Visualization of PCR Products  
 
2% agarose gel was prepared with 1X TAE buffer and 1 mg/mL ethidium 
bromide solution. Samples were prepared by addition of 5 µl Agarose Gel Loading 
dye to 10 µl of cDNA sample and loaded to the agarose gel. Agarose gel was run at 
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90V for 45 minutes and visualized under transilluminator (Gel-Doc BIO-RAD, USA 
and Vilber Lourmat, France). Chemicapture (Vilber Lourmat, France) software was 
used to take photographs of the gels. The low range DNA ladder (Jena Biosciences) 
was used as a marker and 5 µl was loaded to every gel. 
 
3.8. The Real-Time RT-PCR Studies 
 
 The real time RT-PCR was done with DyNAmoTM HS SYBR® Green qPCR 
Kit (Finnzymes, Finland) according to the manufacturer’s protocol. Rat TLR primer 
sequences were adopted from Hubert et al (2006) and the house keeping gene was 
selected to be cyclophillin (CYC) (Table 3.3). Before the real time RT-PCR, the 
efficiencies of the primers were tested using a standard dilution series. The reaction 
conditions of real-time PCR are shown in Table 3.4. 
 
The real-time PCR reactions were carried out in iCycler™ (Bio-Rad, 
California, USA). After the amplification steps melting curve analysis was done. 
 
 Cyclophillin (CYC) gene was used as internal control. Samples from partial 
hepatectomized (PH) and sham (SH) animals obtained at different time points (please 
see Section 3.2) were detected in duplicates, and the readings from each sample and 
its internal control (CYC) were used to calculate gene expression level. 
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Table 3.3. The sequences and the sizes of the rat TLR primers used in this study 
(adopted from Hubert et al., 2006). 
 
Gene 
Acronyms 
                      Primer Sequences Product 
Size (bp)
 TLR1 Forward 
Reverse 
CAGCAGCCTCAAGCATGTCT 
CAGCCCTAAGACAACAATACAATAGAAGA 
82 
 TLR2 Forward 
Reverse 
CTCCTGTGAACTCCTGTCCTT 
AGCTGTCTGGCCAGTCAAC 
74 
 TLR3 Forward 
Reverse 
GCACTGTGAGATACAACGTAGCT 
GAAGGTCATCAGGTATGTGTGTCA 
66 
 TLR4 Forward 
Reverse 
TGCTACAGTTCATCTGGGTTTCTG 
CTGTGAGGTCGTTGAGGTTAGAAG 
78 
 TLR5 Forward 
Reverse 
GGGCAGCAGAAAGACGGTAT 
CAGGCACCAGCCATCCTTAA 
61 
 TLR6 Forward 
Reverse 
AGAACCTTACTCATGTCCCAAAAGAC 
AGATCAGATATGGAGTTTTGAGACAGACT 
79 
 TLR7 Forward 
Reverse 
GTTTTACGTCTACACAGTAACTCTCTTCA 
TTCCTGGAGGTTGCTCATGTTTT 
75 
 TLR8 Forward 
Reverse 
GGCTTCGGCAGAGGATCT 
GCCAAAACAAGTTTTCCGCTTTG 
75 
 TLR9 Forward 
Reverse 
CCGAAGACCTAGCCAACCT 
TGATCACAGCGACGGCAATT 
70 
 TLR10 Forward 
Reverse 
CTCCAACATGGCTTTAAGGAAGGT 
TGGAATTGATAGAGGAGGTTGTAGGA 
90 
 CYC Forward 
Reverse 
GGGAGGGTGAAAGAAGGCAT 
GAGAGCAGAGATTACAGGGT 
211 
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Table 3.4. Reaction composition for real time PCR 
 
Reaction Mixture Volume 
cDNA 1 µl 
2X DyNAmo HS Master Mix 10 µl 
10 pmol forward primer (Alpha DNA) 1 µl 
10 pmol forward primer (Alpha DNA) 1 µl 
ddH2O 7 µl 
Mineral oil 10 µl 
Total 30 µl 
 
3.9. Administration of CM-DiI Labeled Mesenchymal Stem Cells to Partially 
Hepatectomized Rats 
 
3.9.1. Chloromethylbenzamido-1,1–dioctadecyl-3,3,3’,3’-Tetramethylindocarbo- 
cyanine Perchlorate (CM-DiI) Labeling 
 
 A stock solution of 2 mg/mL Chloromethylbenzamido-1, 1–dioctadecyl- 
3,3,3’,3’-tetramethylindocarbocyanine perchlorate (CM-DiI, Molecular Probes, 
USA) was prepared in dimethyl sulfoxide (DMSO) and stored at -20°C. 2x106 of 
cells isolated form normal, one day and three days after PH were stained with CM-
DiI at a concentration of 5 µg/mL in 1X PBS. The flasks were first incubated for 5 
minutes at 37°C and further for 15 minutes at 4°C. After washing twice with PBS, 
MesenCult was added to the flasks. The cells were left in the CO2 incubator for 
further use. 
 
3.9.2. Preparation of Labeled Mesenchymal Stem Cells For in vivo Injection 
 
Four days after CM-DiI labeling, the cells were taken form flasks by 
trypsinization. The cells were first washed with PBS buffer in order to eliminate the 
non-adherent cells in the media. Then the cells were trypsinized and incubated at 
37oC for 5 minutes. Low Glucose DMEM (with 10% FBS) was added to the 
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trypsinized cells and centrifuged at 1500 rpm for 5 minutes. Then the media was 
removed and the precipitated cells were washed with PBS buffer and centrifuged 
again at 1500 rpm for 5 minutes. 10 mL of PBS was added to trypsinized cells and 
they were counted on hemocytometer. The cell concentration was adjusted to 1x106 
cells/mL for all injections (the cells were chilled on ice until administration). 
  
3.9.3. Administration of Labeled Mesenchymal Stem Cells to PH Rats 
 
 Rats were hepatectomized as mentioned in section 3.3.2. CM-DiI labeled 
MSCs, which were isolated from normal rat, were injected to PH animals (1, 3, and 5 
days following partial hepatectomy operation 1-2 animals/time point) as well as 
normal rats through tail vein in a volume of 1 mL. Other labeled MSCc that were 
isolated from both 1 day and 3 day PH rats, were injected only to 3 day PH and naive 
animals. 3 days after administration of labeled MSCs, all the animals were sacrificed 
and their organs (liver, heart, kidney, and spleen) were removed and stored for 
further studies. 
 
 In order to investigate the localization and existence of the CM-DiI-labeled 
cells from different tissues under fluorescence microscope, 5 µm tissue sections were 
taken and the specimens were mounted using UltraCruzTM (Santa Cruz) mounting 
medium with DAPI and covered for further study. 
 
3.10. Immunofluorescence Staining 
 
For immunofluorescence staining, 5 µm sections were taken from frozen liver 
tissues.  The tissues were fixed in 4% paraformaldehyde for 30 minutes and washed 
with dH2O. Then the sections were immersed in 3% H2O2 for 30 minutes. After 
washing with PBS for 2 minutes, the specimen was blocked with 2% BSA for 1 hour 
at RT in humid chamber. Sections were then incubated with FLT3 (Santa Cruz 
biotechnology) and CD90 (Chemicon International) at RT for one hour in a dilution 
1/50 and 1/500 in 1% BSA, respectively. Blocking peptide specific to FLT3 in the 
3/50 dilution was incubated with FLT3 antibody. After washing the sections twice 
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with PBS, the specimen was incubated with FITC-labeled anti-mouse IgG (Sigma) 
with FITC-labeled anti-rabbit IgG (Sigma) for CD90 and Flt3, respectively. The 
sections were incubated in dark for 1 hour at RT in humid chamber. After washing 
with PBS, the specimens were mounted using UltraCruzTM (Santa Cruz) mounting 
medium with DAPI and covered for further study. 
 
3.11. Fluorescence Microscopy Studies 
 
CM-DiI, CD90, FLT3, DAPI stainings were investigated under the 
fluorescence microscope (Leica TCS/SP5, JAPAN) equipped with Lecic software for 
image analysis at an excitation wavelength 359 nm for DAPI, 464 nm for FITC and 
553 nm for CM-DiI. The images were taken by 10X, 25X, 40X and 63X objectives 
with or without water immersion.   
 
3.12. Isolation of The Bone Marrow From The Animals 
 
After the animals were sacrificed by cervical dislocation, the gastrocnemius 
region was shaved with a razor. Then, the femur and tibia were removed, and the 
ends of bones were cut and flushed with DMEM (Invitrogen) which contains 10% 
FBS (HyClone) and 1% penicillin/streptomycin solution (HyClone), by using a 5 mL 
syringe, with a 26 gauge needle (Figure 3.2.). The mixed media and bone marrow 
were centrifuged at 4000 rpm for 3 minutes. Then the media was removed and the 
cells were washed four times with PBS to prepare for tissue culturing.       
 
 
 
Figure 3.2. The isolation of the bone marrow of the rats 
 
 33
3.13. TLR Mediated Morphological Changes of MSC 
 
In order to examine effect of individual TLR ligands on morphology and 
possibly differentiation potential of mesenchymal stem cells, the cells were 
stimulated with TLR ligands as indicated in section 3.4.4. Stimulation was repeated 
with ligand replenishment in every 3 days. 
 
Light microscope images were taken at day 12 after 4th stimulation using 
Nikon (Eclipse TS100) microscope. 
 
3.14. Enzyme Linked-Immunoabsorbent Assay (ELISA) 
 
3.14.1 Cytokine ELISA 
 
Polysorp (F96 Nunc-Immunoplate, NUNC, Germany) plates were coated (50 
µl/well) with anti-cytokine IL6, TNFα, IFNγ monoclonal antibodies (Pierce, 
Endogen USA) in PBS, final concentrations  10µl/mL, 5 µl/mL and 5 µl/mL 
respectively for 4-5 hours at RT (or overnight at 4oC). The wells were blocked with 
200 µl blocking buffer for 2 hours at RT and washed 5 times with ELISA wash 
buffer for 5 minutes. After washing, the wells were rinsed with ddH2O and blot 
dried. Supernatants and serially diluted recombinant proteins of IL6 (starting 
concentration: 2000 ng/mL), TNFα (starting concentration 2000 ng/mL), IFNγ 
(starting concentration 2000 ng/mL) were added and incubated for 1-2 hours at RT 
(or overnight at 4oC). Plates were washed in similar fashion as mentioned above. For 
detection of cytokine levels, biotinylated anti-cytokine antibodies (Pierce, Endogen) 
were prepared in a T-cell buffer, (at a 1:1000 dilution, 50 µl/well) added to the wells 
and incubated for 2 hours at RT (or overnight at 4oC). After washing the wells as 
described above, 1:5000 diluted Streptavidin Alkaline-phosphatase (SA-AKP) was 
prepared in T-cell buffer and added to the plates (50 µl/well) for 1 hour at RT. After 
washing the plates; PNPP substrate (one tablet/5 mL PBS, 50 µl/well, Pierce, USA) 
was added and incubated. Continuous ELISA was performed to plates and after color 
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formation, multiple OD readings (at 405nm) were recorded on an ELISA plate reader 
(BioTek, µQuant, USA). 
 
 In order to determine concentrations of cytokines from cell supernatant, 4-
parameter standard curves were constructed from recombinant proteins as mentioned 
above. 
 
3.15. Magnetic Bead Cell Separation  
  
MSCs are separated with Dynabeads®TM M-450 Epoxy magnetic beads 
(DYNAL®, Invitrogen™) coupled with CD34 antibody (Santa Cruz) according to 
the manufacturer’s protocol. Briefly, 100 µl of Dynabeads were taken from stock and 
washed by placing the tube in a magnet (Dynal MPC®) for 60 seconds by discarding 
the supernatant. Then, the tube was taken from the magnet and the beads were 
resuspended in buffer A (0.1 M phosphate buffer) and mixed for 2 minutes. After 
repeated washing steps the beads were resuspended in a volume of buffer A equal to 
the original particle volume to obtain the recommended final coating concentration 
of 4-8x108 beads/mL. Afterwards, the beads were coated with CD34 antibody adding 
by dissolved antibody into bead solution with a final concentration of 20-40 µg of 
antibody/4-8x 108 beads/mL and incubating the mixture for 16-20 hours at 4-37oC on 
a rotating/rocking rotor.  
 
After isolation, washing and counting of MSCs, as mentioned in Section 3.11 
and in Section 3.4.1., the cells were incubated with coated beads for 30 minutes at 2-
8oC on the same rotor. The tube was placed on the magnet and left to be separated 
for 2-3 minutes and the supernatant was transferred into a new tube as CD34- cells. 
Both CD34- supernatant and CD34+ cell pellets were plated in MesenCult media. 
 
At day 14, CD34+ and CD34- cells were stimulated with TLR ligands as 
mentioned in section 3.4.4., and IL6 secretion were examined in response to 
indicated TLR ligand stimulation by sandwich ELISA.  
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3.16. Flow Cytometric Analysis of Cell Surface Markers  
 
3.16.1. Fixation of Cells 
 
Mesenchymal stem cells from different passages were first washed with PBS 
in order to eliminate the non-adherent cells in the culture and were removed from 
flasks by scraping. The cells were transferred into falcon tubes and centrifuged at 
1500 rpm for 5 minutes. The cell number was adjusted to 1-4x106cells/tube and 
pelleted. After dislodging the cells, 100 µl of fixation medium A (Fix & Perm®, 
Caltag Lab. USA) per tube was added while vortexing for 10-20 seconds, the tubes 
were incubated at RT for 15 minutes. 2 mL of PBS-BSA-Na-Azide was added to the 
tubes. The tubes were centrifuged at 1500 rpm for 5 min and supernatant was 
discarded. The pellet was resuspended in 1 mL PBS-BSA-Na-Azide and stored at 
4oC at most for a week until for further use.  
 
3.16.2. Surface Marker Staining  
 
After dividing cells into four different falcon tubes, the tubes were 
centrifuged at 1500 rpm for 5 minutes. In order to prevent non-specific binding of 
antibodies, 0.5 µl of Fc block was added to each tube in 49.5 µl PBS-BSA-Na-Azide. 
After blocking, the cells were stained with CD90-FITC (Thy 1.2, Abcam, USA), 
CD45-PE/Cy5 (Abcam), CD11b-PE (ImmunoTools™, Germany), CD117-FITC (c-
Kit, ImmunoTools™) for 30 minutes in dark at RT. Moreover, some cells were 
stained with FITC-labeled rat anti-mouse IgG to serve as isotype control. The cells 
were washed twice by adding 2 mL PBS-BSA-Na-Azide and centrifuging at 1500 
rpm for 10 minutes. Finally the cells were resuspended in 500 µl of PBS-BSA-Na-
Azide or PBS and transferred to FACS tubes, for analysis. 
 
3.16.3. Flow Cytometric Analysis of Cells 
 
Samples were analyzed (10,000–50,000 events) on a FACS Calibur 
instrument (Becton Dickinson, San Jose, CA) after gating on live cells with proper 
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electronic compensation. The data were analyzed using CELLQuestPro software 
(Becton Dickinson Immunocytometry Systems, San Jose, CA). 
3.17. Statistical Analysis 
 
 Statistical significance between animal groups was determined using 
Student’s t–test analysis. 
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4. RESULTS 
 
4. 1. MSC Homing In Partial Hepatectomized Rats 
 
4.1.1 Administration of MSC From Normal Rat  
 
Mesenchymal stem cells are multipotent progenitor adult cell population 
capable of differentiating into several lineages including adipocytes, osteoblasts and 
chondrocytes, and nerve cells (Pitteger et al, 1999; Woodbury, 2000). Moreover, 
MSC is able to migrate to the damaged tissue in (vivo Baksh et al, 2004). The 
mechanism of this phenomenon is still elusive. We have hypothesized that one 
mechanism triggering the MSCs to accumulate at these sites is the TLR expression 
ability of the host organ (or tissue). To demonstrate that this we have designed a set 
of experiments to investigate whether MSCs given systemically localize to the site of 
injury, we hepatectomized rats and then injected MSCs either prepared from already 
hepatectomized or normal animal bone marrows. In order to understand homing 
property of MSCs in partially hepatectomized rats, MSCs (from normal animals) 
were labeled with CM-DiI (see appendix B section) and administered into 1, 3, and 5 
day post-PH and normal rats through their tail vein (Figure 4.1.). At the end of 3 days 
of post MSCs administration, animals were sacrificed, the liver and several other 
organs and fixed. The liver was sectioned and stained with DAPI.  
 
 As shown in Figure 4.1. our findings showed that a thin layer of CM-DiI 
positive MSCs localized at the outermost layer of the PH liver were detectable from 
the ultra thin sections of 3 day PH animals (please examine Figure 4.1. H). The livers 
studied for day 1 and 5 PH animals including normal and untreated livers gave no 
detectable CM-DiI specific signal.  
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4.1.2 Administration of MSC From Hepatectomized Rats 
 
 It is also established in the literature that the critical time frame for the 
recovery of PH animals is the first 72 hours. Extending this observation we have 
postulated that the mobilization of MSCs in these hepatectomized animals may be 
different than normal rats. For this, we asked the question whether we can monitor 
any change in the localization yield of the MSCs isolated from day 1 or day 3 PH 
animals when they are administered into 3 day PH (or as a control group to normal 
rats) animals from their tail vein (Figure 4.2.). 
 
Our results indicated that MSCs isolated from 1 day PH rat rather than 3 day 
PH animal is localized in the liver of 3 day PH liver in a similar fashion as seen in 
the case of MSC isolated from normal rat (section 4.1.1. and Figure 4.1.). However, 
no CM-DiI staining was observed in liver of rats that were injected with MSC from 3 
day PH rat. This set of data implicate that, bone marrow cells isolated either from 
normal or day 1 PH rats can yield MSCs with a recruitment capacity to the site of 
injury (localize only to post injury day 3 only). 
 
4.1.3. CD90 Expression in Hepatectomized Livers 
 
 Observing the CM-DiI positive MSC presence in post day 3 PH liver was 
encouraging. We further wanted to understand if there are additional MSCs from 
recipient animal in the niche of the injured organ that may play additional role 
mediating liver regeneration. One of the widely accepted surface markers for 
mesenchymal stem cells in rodents is CD90 (Thy1.2) (Mangi et al, 2003). Therefore, 
we performed immunofluorescent staining (IF) to investigate the presence of MSCs 
in DiI-labeled MSC administered hepatectomized liver sections (Figure 4.3.). We 
have stained the sections with anti-CD90- FITC labeled antibody for MSC presence 
and investigated under fluorescence microscope. 
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41
  
 
 
A B
C D
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Photomicrograph showing CD90 expression in 3day post PH liver 
sections that received MSC generated from normal rat BM (Magnification 20X). (A) 
DAPI, (B) DiI, (C) CD90-FITC and (D) another area for CD90-FITC positive cells 
 
 
  As seen from IF micrographs, the results showed that there were several 
CD90 positive cells scattered around DiI-labeled MSCs in the liver section of 3 day 
PH rat (Figure 4.3. C & Figure 4.3. D). Consistent with earlier observations no 
specific CD90 staining was observed for i) normal, ii) post 1 day or iii) post 5 day 
PH rats (data not shown). Surprisingly, we have not been able to co-stain the cells 
positive for CM-DiI with CD90. One explanation is that, DiI is a dominant dye and it 
may bleed through to the excitation range of FITC which results in masking of FITC 
specific staining. Another plausible explanation is that, these cells have down-
regulated their surface CD90 (after injected through tail vein) when they reached 
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hepatectomized liver and since they are interacting with the surrounding cells if they 
are secreting certain mediators, it is possible to undergone certain phenotypic change 
and downregulate certain MSC specific markers while upregulating others (or 
secreting certain factors). 
 
4.1.4. Flt3 Expression in Hepatectomized Livers 
 
 Flt3 is a receptor tyrosine kinase (RTK) and a well-known hematopoietic 
stem cell marker (Peterson, 2001; Agnes et al, 1994). Oval cells are playing pivotal 
role in progenitor-dependent liver regeneration and are known to express specific 
proteins at the surface among these FLT3 is one of these proteins (Alison M, 1998). 
Thus, we performed immunofluorescent staining against FLT3 (labeled with FITC) 
to check the existence of hepatic oval cells in DiI-labeled MSC administered 
hepatectomized livers. As expected, Flt3 positivity can be seen around DiI-labeled 
MSCs in the liver of post 3 day PH rat (Figure 4.4.). When Figure 4.4 is investigated 
in detail, it is clearly evident that around the DiI positive MSCs a bright green cell 
population is seen. When these images merged (please check Fig 4.4. D) FITC 
positivity is abundant around bright yellow areas where MSCs are residing. 
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 A DCigure 4.4. Photomicrograph showing Flt3 expression in 3day post PH liver sections 
hat received MSC generated from normal rat BM (Magnification 20X). (A) DAPI, 
B) DiI (C) Flt3-FITC and (D) Merged 
.2. Real Time RT-PCR Results 
Our aim throughout this study is to establish the orchestral contribution of the 
SC administration in addition to the expression profile of several TLRs during 
iver regeneration. As explained in the earlier sections, we have been able to detect 
SC (labeled with DiI) in liver sections at post 3 day following hepatectomy. We 
ere curious to link this phenomenon to TLRs.  In this section results regarding the 
tatus of TLR expression profiles of several treatments will be covered.   
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 For real-time RT-PCR studies the cDNA samples of sham (see appendix C), 
partial hepatectomized (PH), and MSC-administered PH groups were used. The real-
time PCR reactions were performed as explained in section 3.7. Efficiency of CYC 
and TLR1 to 10 primers were tested, standard curves were derived and E values were 
calculated for all primer sets (Table 4.1) 
 
Table 4.1 Efficiency values of primer sets used during real-time RT PCR studies 
 
Primer set E value 
CYC 1,9 
TLR1 1,94 
TLR2 1,94 
TLR3 1,98 
TLR4 1,88 
TLR5 1,86 
TLR6 1,99 
TLR7 2 
TLR8 2 
TLR9 2 
TLR10 1,9 
 
 
4.2.1. TLR Expression in Partial Hepatectomized Rats 
 
The Ct values of normal liver, and PH groups (post PH at 2, 4, 12, 18 and 24 
hours) for TLR genes and CYC were calculated. The Ct values of the PH groups were 
normalized according to their difference from the Ct value of normal liver sample. By 
using normalized Ct values, ∆Ct (∆CtTLR gene / ∆CtCYC) value for each TLR at indicated 
time of was calculated. Fold change in expression of all the tested TLR genes were 
calculated by using 2-(∆CtPH - ∆CtNL) formula (which is specific to each tlr gene primer 
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sets including cyclophilin set) (data not shown). From these values fold change in 
expression for each TLR is plotted (Fig 4. 5. A to F). 
 
From these plots, it was apparent that specifically three genes (tlr2, tlr3, and 
tlr9) gave unchanged expression profile over the course of 24h post PH (Fig 4.5A, 
4.5 B, and 4.5 F).These genes, are triggered by RNA, CpG DNA, and a well known 
bacterial byproduct peptidoglycan, and is reported to be triggered via endogenous 
host ligands after injury. We have selected these genes to monitor the fold change in 
expression upon MSC administration. 
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Figure 4.5 Fold Change in (A) TLR2, (B) TLR3, (C) TLR4, (D) TLR5,  
(E) TLR6 and (F) TLR9 expression in different time points post PH. 
 
4.2.2. Expression of TLRs in MSC Administered PH Groups 
 
The Ct values of PH groups (normal liver vs. 3 and 7 days) and MSC-
administered PH groups (normal liver vs. 3 days) for TLR2, 3, and 9 genes and CYC 
were calculated.  The Ct values of the PH and SH groups were normalized according 
to their difference from the Ct value of normal liver sample. By using normalized Ct 
values, ∆Ct (∆CtTLR gene / ∆CtCYC) value for each group was calculated. Fold change in 
expression of all genes were calculated by using the formula given below (Table 4.2, 
4.3, 4.4): 
                                                                    
           Fold Induction of gene x =    E TLR gene∆Ct(Ct NL- Ct samples)/ E CYC∆Ct(Ct NL- Ctsamples)
 
Where Ct NL is Ct values for normal rat, and Ct samples are Ct values for different 
PH groups                                                    
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Table 4.2 TLR2 real time RT-PCR data for PH and MSC administered PH groups 
 
Group Names CtTLR2* ∆CtTLR2 E
(∆CtTLR2) CtCYC ∆CtCYC** E(∆CtCYC)
E(∆CtTLR2)/ 
E(∆CtCYC)
1 day PH 25.9 1 1.94 15.5 0.6 1.48 1.31 
1 day PH+ MSC from normal rat 25.2 1.7 3.09 16.8 -0.7 0.63 4.89 
3 day PH 27.1 -0.2 0.88 16.8 -0.7 0.63 1.39 
3 day PH+ MSC from normal rat 24.2 2.7 5.99 16.3 -0.2 0.88 6.83 
5 day PH+ MSC from normal rat 25 1.9 3.52 16.8 -0.7 0.63 5.58 
Normal rat +MSC from normal rat 26.5 0.4 1.30 16.7 -0.6 0.67 1.93 
3 day PH+ MSC from 1 day PH rat 24.7 2.2 4.30 16.1 0 1.00 4.30 
Normal rat+ MSC from 1 day PH rat 26.7 0.2 1.14 16.6 -0.5 0.72 1.59 
3 day PH+ MSC from 3 day PH rat 26.8 0.1 1.07 17.2 -1.1 0.49 2.20 
Normal rat+ MSC from 3 day PH rat 26.7 0.2 1.14 17.1 -1 0.52 2.20 
  * CtTLR2 value for normal liver is 26.9. 
** CtCYC value for normal liver is 16.1. 
 
Table 4.3 TLR3 real time RT-PCR data for PH and MSC administered PH groups 
 
Group Names CtTLR3* ∆CtTLR3 E
(∆CtTLR3) CtCYC ∆CtCYC** E(∆CtCYC)
E(∆CtTLR2)/ 
E(∆CtCYC)
1 day PH 
24.9 -1 0.51 15.5 0.6 1.48 
0.34 
 
1 day PH+ MSC from normal rat 24.2 -0.3 0.81 16.8 -0.7 0.63 1.29 
3 day PH 25.4 -1.5 0.36 16.8 -0.7 0.63 0.57 
3 day PH+ MSC from normal rat 23.6 0.3 1.23 16.3 -0.2 0.88 1.40 
5 day PH+ MSC from normal rat 23.9 0 1.00 16.8 -0.7 0.63 1.58 
Normal rat +MSC from normal rat 23.4 0.5 1.41 16.7 -0.6 0.67 2.09 
3 day PH+ MSC from 1 day PH rat 24.7 -0.8 0.58 16.1 0 1.00 0.58 
Normal rat+ MSC from 1 day PH rat 23.9 0 1.00 16.6 -0.5 0.72 1.39 
3 day PH+ MSC from 3 day PH rat 24.9 -1 0.51 17.2 -1.1 0.49 1.04 
Normal rat+ MSC from 3 day PH rat 
23.5 0.4 1.31 17.1 -1 0.52 2.54 
  * CtTLR3 value for normal liver is 23.9. 
** CtCYC value for normal liver is 16.1. 
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Table 4.4 TLR9 Real time RT-PCR data for PH and MSC administered PH groups 
 
Group Names CtTLR9* ∆CtTLR9 E
(∆CtTLR9) CtCYC ∆CtCYC** E(∆CtCYC)
E(∆CtTLR2)/ 
E(∆CtCYC)
1 day PH 
24.9 0.6 1.52 
15.5 0.6 1.48 
1.02 
1 day PH+ MSC from normal rat 24.2 1.3 2.46 16.8 -0.7 0.63 3.90 
3 day PH 25.4 0.1 1.07 16.8 -0.7 0.63 1.70 
3 day PH+ MSC from normal rat 23.6 1.9 3.73 16.3 -0.2 0.88 4.26 
5 day PH+ MSC from normal rat 23.9 1.6 3.03 16.8 -0.7 0.63 4.80 
Normal rat +MSC from normal rat 23.4 2.1 4.29 16.7 -0.6 0.67 6.36 
3 day PH+ MSC from 1 day PH rat 24.7 0.8 1.74 16.1 0 1.00 1.74 
Normal rat+ MSC from 1 day PH rat 23.9 1.6 3.03 16.6 -0.5 0.72 4.21 
3 day PH+ MSC from 3 day PH rat 24.9 0.6 1.52 17.2 -1.1 0.49 3.12 
Normal rat+ MSC from 3 day PH rat 
23.5 2 4.00 
17.1 -1 0.52 
7.72 
  * CtTLR9 value for normal liver is 25.5. 
** CtCYC value for normal liver is 16.1. 
 
Of three TLR genes tested, TLR3 gave the lowest fold change in message 
(Figures 4.6.).  Our results revealed that TLR2, TLR3 and TLR9 mRNA expression 
levels increased in liver samples of partially hepatectomized rats that received 
labeled MSC in comparison to those animals that did not have any MSC treatment 
(Table 4.2., 4.3., 4.4. and Figure 4.6. A, C, and E). The state of recovery does not 
influence this feature (i.e. whether the animal is day 1 or day 5 post operation). For 
PH animals after MSC (generated from normal rat) treatment, TLR2 and TLR9 fold 
change in expressions were significantly higher to that of TLR3 expression change 
(ca. 7 fold to 2 fold). It is fair to generalize that upon administration of MSCs 
(irrespective of MSC source) all three TLR expression levels increased for 
hepatectomized rats and decreased or remained unchanged for normal rat livers 
(compare Figs 4.6. B, D, F). 
  
 These data suggest that upon MSC injection tlr gene expressions dramatically 
increase in PH animals. This increase is not dependent on the hepatectomy but rather 
depends on the mediators/factors secreted from MSCs. When microscopic and PCR 
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data are taken together, MSC effect on TLR expression could be either trans or cis, 
since in the absence of MSCs residing at that site, of injury (lack of DiI signal) we 
still detect upregulation at day 1 and 5 post PH treatment. 
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Figure 4.6. Fold change in (A, B) TLR2, (C, D) TLR3 and (E, F) TLR9 expression in 
PH and MSC-administered PH groups 
 
4.3 Efforts to Delineate MSC Functions   
 
 Besides regeneration and tissue repair, MSCs are suggested to have role in 
immuneregulation (Ramasamy et al, 2007). It is shown both in vivo and in vitro that 
MSCs are not inherently immunogenic. In addition, they are called ‘universal 
suppressor of immune system’ having suppressive effect on different subsets of 
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immune cells (Maccario et al, 2005). Although they are claimed to be non-
immunogenic, murine MSCs have shown to express several TLR receptors 
(Pervsner-Fischer et al, 2007). This paradoxical evidence suggests that MSCs could 
recognize several microbial by products collectively known as pathogen-associated 
molecular patterns. Considering accumulated data on immunosuppressive action of 
MSCs, the recent evidence suggest that either the TLRs are not functional or do not 
respond to their corresponding ligands even though they are present on MSCs or 
MSCs possess subpopulations that are either positive or negative for different TLRs.  
Until now the extent of TLR responsiveness on MSC at `passage 0` was not explored 
in detail by others. We aim to understand the molecular mechanism of the 
immuneregulatory function of mesenchymal stem cells (MSCs). Different from the 
previous sections, instead of rat we shift to mouse for these studies. The major reason 
for this change is because our stimulation and detection assay reagents are well 
established for mouse system. 
 
4.3.1. TLR Expression Pattern of Mesenchymal Stem Cells and Spleen Cells 
 
In this study; mouse MSCs were generated from bone marrow cells and 
incubated for two weeks in mesencult media.In all experiments the cells were used at 
passage 0 unless otherwise stated.  
 
We first wanted to identify the TLR expression profiles of generated naive 
MSCs. As seen in Figure 4.7. MSCs at the end of 14 days of incubation were 
harvested and studied for indicated TLR genes from the purified total RNA we 
observed that they are expressing all known TLR mRNA as evidenced by PCR.  
 
This piece of evidence can only establish that MSCs as well as mouse spleen 
cells (known to express several TLRs) have endogenous TLR message. Furthermore, 
different from naive spleen, MSCs are expressing TLR 1, 2, 3, 4, 5 (albeit at low 
level), 6, 7 and 9, whereas under the tested conditions we were unable to detect basal, 
tlr5 , tlr7 and tlr9 message from splenocytes. 
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 Table 4.5. Product size of mouse TLRs and β actin 
 
Gene Name Product Size (bp) 
mTLR1 410 
mTLR2 320 
mTLR3 250 
mTLR4 240 
mTLR5 380 
mTLR6 650 
mTLR7 700 
mTLR9 430 
m-β actin 450 
 
  
  tlr1     tlr2      tlr3      tlr4      tlr5     tlr6       tlr7      tlr9    β actin  
 
 mMSC 
SPLEEN 
 
Figure 4.7. Variations in the TLR expression profile between mouse MSC (top 
panel) and spleen cells (bottom panel). Total RNA from murine splenocytes and 
MSCs were subjected to RT-PCR and tlr1 to tlr9 specific bands were visualized on 
agarose gel. 
 
4.3.2. Immunoregulatory Effects of Mesenchymal Stem Cells 
 
The detection of message is not directly indicative of the functionality of the 
receptor. There are several ways to test this. Since immunosuppressive action of 
MSCs are well established we reasoned that if we treat spleen cells with the 
corresponding TLR ligands, and co-culture with varying numbers of MSCs (even 
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though MSCs seem to possess TLR message) the stimulatory action of these ligands 
could be suppressed. Furthermore depending on the titrated MSC number this 
suppression may subside, thus implicate us that MSCs are immunosuppressive. 
 
Splenocytes were plated as described in section 3.4.4. and following the 
addition of MSCs (cell number ratio ranged from 1:1 to 1:10000 MSC to Spleen 
cells) were   stimulated with the indicated TLR ligands (i.e. for TLR2/6: PGN (5 
µg/ml), TLR3: dsRNA (20 µg/ml), TLR4: LPS (1 µg/ml), TLR7/8: ssRNA or 
imiquimod (1 µg/ml) and TLR9: CpG DNA (1 µM)). The cells were stimulated for 
48 h and supernatant was collected. Sandwich ELISA to detect IL6 production was 
studied from the supernatants (Figure 4.8.).  
 
Unexpectedly, there was no significant suppression of the IL6 level. On the 
contrary, inclusion of MSCs in the spleen culture augmented cytokine secretion from 
spleen cells. This led us to test MSC only and spleen only induction and compare 
their IL6 production to that of co-culture experiments. As seen in Figure 4.8, MSCs 
by themselves when triggered by ligands were able to secrete IL6 in many cases at 
much higher level than spleen alone group (compare the induction levels of pI:C, 
LPS, R848 between MSC only and Spleen only groups in Figure 4.8. H and I 
responses). In particular, IL6 levels in response to pI:C and LPS stimulation 
synergize with increasing number of MSCs included in the splenocyte culture.  
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Figure 4.8. IL6 production after 48h stimulation of different ratios of MSC-
Splenocyte co-culture with different TLR ligands. (A) Naive , (B) Control ODN: 
FlipCG1555 (1 µM), (C) TLR9: CpG ODN 1555 (1µM) , (D) TLR3: pI:C 
(20µg/mL), (E) TLR2/6: PGN (5 µg/mL), (F) TLR4: LPS (1 µg/mL), (G) TLR7: 
R848 (1 µg/mL), (H) MSC alone stimulated with all ligands and (I) Splenocyte alone 
stimulated with all indicated ligands. 
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4.3.3. Bone Marrow Cell Separation Before MSC Generation 
 
The immunostimulatory activity of MSCs could be due to contaminating cells 
remained in the culture; another possibility could be the existence of other MSC 
subsets within the population.  
 
In addition to adherence method, after extraction of bone marrow cells one 
other approach is to separate BM cell population based on their CD34+ marker 
(separation of hematopoietic and non hematopoietic cells). We then wanted to 
understand what cell fraction is responsible from the immunomodulatory properties 
of the MSC.  
 
 In order to generate MSCs magnetic bead isolation method was selected. 
Cells were incubated with CD34 coated magnetic beads as described in section 3.15. 
After separation, cells were cultured in separate flasks as CD34- and CD34+ 
populations. At the end of 14 days in mesencult culture, as explained earlier (see 
section 3.4.4.) stimulation assay using several TLR ligands was conducted. IL6 
levels of CD34-and CD34+ MSC cells were detected in response to PGN, pI: C, 
LPS, CpG ODN1555, and Control ODN (Figure 4.10 A and B). 
 
We have expected to detect different IL6 production profiles from these sub 
populations but to our surprise both populations induced similar levels of IL6. 
Collectively, our results revealed that MSCs regardless of CD34 expression were 
secreting IL6 in response to indicated TLR ligands.  
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Figure 4.9. IL6 production after 5 days stimulation of (A) CD34- and (B) CD34+ 
cells with different TLR ligands.  
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4.3.4. MSC Characterization by Flow Cytometry  
 
When culturing MSCs, according to accumulating evidence; as passage 
number increases cell surface marker expression of the MSC population varies. 
While the percentage of expression of certain markers increases certain others 
become more negative among MSC cell population. Characterization of murine 
MSCs is still a huge challenge since limited numbers of cell surface markers are 
available. In that respect, ongoing studies are planned to determine whether certain 
candidate markers may be reproducibly used to characterize murine MSCs using 
flow cytometric approaches.  
 
In order to analyze the percentage change of MSC specific markers and also 
delineate the  change in the contaminating cell fraction proliferating along with 
MSCs we have decided to follow the expression of several positive and negative 
markers such as i) CD90 (Thy 1.2), ii) CD45 , iii) CD11b , and iv) CD117 by flow 
cytometry (Figure 4.11). Our results showed that the MSC population became more 
CD45 and CD11b positive and CD117 negative. (Figure 4.11., Table 4.6), CD90 
expression decrease significantly at passage 3.  
 
It is very unfortunate that there is no specific surface marker widely accepted 
as indicative of MSC generated from BM. At this stage we can not confidently say 
that we have generated MSCs of mixed population or there are contaminating cells 
that dominating the culture. But can only conclude that there are couple of markers 
expressed by these cells at the end of 14 day culture, and suggest that our cell 
population we have substantial amount of MSC. 
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A) Passage # 1 
 
 
 
 
 
B) 
 
 
B) Passage # 3 
 
 
 
 
 
 
 
Figure 4.10. Surface marker expression change of different MSC passages. MSC 
from (A) passage number 1 and (B) passage number 3 were fixed and labeled with 
FITC-CD90, PE/Cy5-CD45, PE-CD11b and FITC-CD117. 
 
Table 4.6. Expression of surface markers in different passages 
 
Single or double 
positive % of cells 
Passage # 1 Passage # 2 Passage # 3 
CD90  87.8 91.2 22.6 
CD45  89.4 91.6 80.6 
CD11b  87.2 88.7 86.9 
CD117 0,64 1.1 2 
CD90-CD45  79.5 84.3 21.6 
CD90-CD11b  79.6 84.9 20.6 
CD117-CD11b  0.6 1 0.9 
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4. 5. TLR Mediated Proliferation and Morphological Changes of Murine 
Mesenchymal Stem Cells 
  
 In order to check effect of TLR ligands on the morphology of MSCs, we 
stimulated MSCs (106cells/well) with Control ODN, CpG, pI: C, PGN and 
Gardiquimod in every 3 days as described in section 3.4.4. TLR mediated 
morphological changes were observed at the end of day 12 of continuous stimulation 
(Figure 4.11.). In particular, TLR3 ligand p:IC seems to have detrimental effect on 
MSCs. Moreover, PGN and Gardiquimod seem to have a proliferative effect on 
MSCs. 
 
 In this study, we have found that CM-DiI labeled MSCs, generated from 
normal rat, are localized particularly in the liver of 3d post PH rats. Homing capacity 
of them are seemed to be decreased when MSC are generated form 3d post PH rats. 
Moreover, endogenous MSCs (CD90 positive) and hepatic oval cells (Flt3 positive) 
are found to be localized around CM-DiI labeled. Although mechanism is unclear, 
that observation is interesting in terms of attributing a role to MSCs in liver 
regeneration. Another intriguing observation is that MSC seems to increase TLR 
mRNA expression, particularly, TLR2, 3 and 9, in post PH rats. This may be another 
potential mechanism of MSC and also TLR contribution to liver regeneration 
process. Second part of my study concentrate on mostly characterization of MSCs 
since .We found that MSC express several TLRs and functionality of TLRs are 
confirmed by cytokine ELISA assay. In accordance with these data, change in the 
cell surface markers in different passages and different morphological and 
proliferative responses of MSCs to TLR ligand make us to think either there is a sub-
population or contaminating cells in our MSC population. 
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5. DISCUSSION 
 
 In this study, we aimed to understand whether liver regeneration have an 
effect on homing properties of bone marrow derived MSCs and also whether MSCs 
have a role in liver regeneration. Moreover, potential role of TLRs in both liver 
regeneration and their immunoregulatory properties are aimed to be elucidated. 
 
Although Popp et al. (2007) reported that multipotent mesenchymal stromal 
cells from rat do not differentiate into hepatocytes in vivo when transplanted in 
regenerative conditions, Lee et al. (2004) has shown that bone marrow-derived 
mesenchymal stem cells from human differentiate into functional hepatocyte-like 
cells under defined conditions pointing out the potential for clinical applications. 
They have recently showed that these cells can effectively rescue experimental liver 
failure (upon CCl4 administration) and contribute to liver regeneration. Thus, these 
can be used as an alternative therapy to organ transplantation for the treatment of 
liver diseases (Kuo et al., 2008). These data make us to think about the potential 
involvement of mesenchymal stem cells in experimental liver regeneration process 
using hepatectomized rat (PH) as a model. In order to investigate homing of MSCs in 
liver after PH, CM-DiI labeled MSCs were administrated to 1d, 3d and 5d PH rats. 
Our results revealed that only in 3 day PH rat, MSC were localized in liver. On the 
other hand, MSC localization was not observed in the liver of either 1d PH or 5d PH 
rats.  
 
Homing property of MSCs is also investigated in MSCs generated from 1 day 
post PH and 3 day post PH bone marrow. Although MSCs obtained from 1 day post 
PH rats is also localized in the liver of 3 day post PH rat, localization of MSC could 
not be seen in liver of 3 day post PH rat when MSCs are generated from 3 day post 
PH rats. This observation leads to the question of whether there may be a negative 
contribution of PH in homing property of MSCs. 
 
Next, we asked the question of whether endogenous MSCs also show the 
similar homing pattern to allogeneic MSCs during liver regeneration in terms of 
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timing and localization. The IF data from CD90 immunostained liver sections 
revealed that the timing of the appearance of endogenous MSCs are similar to that of 
exogenous allogeneic MSCs. They were seen in the liver regeneration site and 
localized in liver of 3d post PH which is remarkably similar to that of exogenous 
allogeneic MSCs injection. Other emerged question is why allogeneic MSC do not 
express CD90. A possible answer may be that MSC, as shown by Lee et al. (2004), 
can be differentiated into hepatocyte-like cells, thus cell surface markers may 
change. Therefore one can speculate that, the answer of former question may be 
found in the probable answer of latter question. If exogenous MSC started to 
differentiate into hepatocyte, then they would reside in liver and drive endogenous 
MSC localization. However, this scenario remained to be elucidated in depth. 
 
It is also interesting that, the marker of hepatic oval cells, Flt3 expression, 
was observed only in MSCs administrated into 3 day PH rats in the vicinity of 
labeled MSCs. Expression of Flt3 around this location suggests the onset of 
progenitor-dependent liver regeneration.  
  
 Several studies have shown that multiple pathways play role during liver 
regeneration. Faust et al (2006) proposed that three major pathways may regulate the 
circuitry required for liver regeneration. These are cytokine, growth factor and 
metabolic networks linking liver function to cell growth and proliferation. It is 
proposed that the innate immune system plays an important role in the initiation of 
liver regeneration after partial hepatectomy. In particular, IL6 and TNFα production 
by Kupffer cells are found to be required for initiation of liver regeneration after PH, 
although the activation processes are still unknown. TLRs are important upstream 
elements of proinflammatory cytokine networks. Iimuro et al. showed that IL6 and 
TNFα production decrease significantly leading to defective liver regeneration in 
MyD88-/- mice after PH. However, it was also shown that TLR 2, 4 and 9 are not 
essential for NF-κB activation and IL6 secretion (Campbell et al, 2006; Seki et al, 
2005). The latter observation is particularly surprising since enteric-derived LPS 
(ligand of TLR4) was shown as the stimulating agent for proinflammatory cytokine 
production at the start of liver regeneration (Cornell, 1985; Cornell, 1990; Shiratori, 
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1996). Therefore, we decided to investigate the mRNA expression of TLR2, 4, 9 as 
well as TLR 3, 5, 6 in 0h, 2h, 4h, 12h, 18h and 24h after PH. Our results revealed 
that induction in the expression of TLR 2, 3, 4, 5 and 9 do not exceed 1 to 2 fold in 
all time points compared to the expression seen for normal animals at 0h. On the 
other hand, TLR6 mRNA expression increases 3, 5 fold in 18h PH group. Since 
TLR6 function requires dimer formation with TLR2 and no significant upregulation 
was seen for TLR2, we reasoned that this upregulation can not be physiologically 
meaningful, but could be a spike appeared due to assay procedure. 
 
As we hypothesized that mechanism of MSC homing to injury site may be 
due to TLR expression ability of the organ in which injury occurs, we investigated 
the relationship between the MSC homing to liver and TLR expression profile in 
response to PH. We particularly choose TLR 2, 3 and 9 since we have found their 
expressions are relatively unchanged over the period of 24 hours after PH. Thus, any 
change in the expression could only be explained by the fact that the injected MSCs 
may contribute to these expression shifts. TLR 2, 3 and 9 expressions were 
investigated in 1d post PH and 3d post PH rats with or without MSC administration. 
Our results revealed that mRNA expression levels of TLR 2, 3 and 9 are increased in 
MSC-administrated 1d PH and 3d PH in comparison to that of liver samples that had 
no MSC injection. Our data suggest that the driving force of MSC homing is not 
related to the increase in TLR expression, rather, MSC homing led to increase in 
TLR gene expression in post PH rats.  
 
When this data along with DiI-labeled MSC immunofluorescence study were 
taken together, the increase in TLR expression by injected MSCs is modulated either 
by cis (at day 3), or effects trans (at days 1 and 5). The absence of MSCs at post PH 
1 and 5d at the liver sections suggest that even though we could not detected the 
labeled cells during fluorescence microscopy the injected MSCs might be still 
secreting certain factors into circulation and these factors are sufficient enough to 
drive the cells of injured liver to increase their TLR expression. 
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One could argue that another possibility for increased TLR expression could 
be due to the presence of the injected MSCs existing at the site rather than the liver 
cells. This is an impossible possibility since we only injected one million cells and 
the amount of tissue used during RNA extraction is in the order of several 
milligrams. 
 
Characterization of MSC is the most challenging aspect of MSC studies. 
There are controversial data showing that MSCs are immunosuppressive but also 
exert immune response through TLR signaling pathways. Although MSCs are 
claimed to be non-immunogenic, Pevsner-Fischer et al (2007) have shown that they 
express TLR1-8. These observations led us to investigate the immunoregulatory 
properties of MSC which is extremely important for MSC based cell therapies. Our 
TLR expression results confirm Pevsner-Fischer data although we also found the 
expression of TLR9 in addition to others. Since mRNA expression may not mean 
functionality of the proteins, we decided to check the immunoregulatory property by 
MSC/splenocytes co-incubation experiments. Surprisingly, there seems no 
suppressive effect induced by MSCs on splenocytes, rather IL6 secretion increases 
with increasing ratio of MSC: splenocyte in response to several TLR ligand 
stimulation. This observation implied that our MSC population could be either 
composed of heterogeneous population or could contain a fraction of contaminating 
adherent cells of hematopoietic origin BM cells (that remained after adherence 
method separation procedure).  We, therefore, further the surface marker expression 
of these MSCs by flow cytometry. Although there is no consensus as to which 
surface markers are useful for MSCs characterization, we used most widely accepted 
CD90 as a positive and hematopoietic stem cell marker (CD45 and CD117) and 
macrophage (CD11b) markers as negative controls.  
 
Our results showed that percentage of surface marker expression changes 
with respect to the increasing passage number. In particular, we found that CD90 
expression decreases significantly at passage 3. There may be two explanations for 
this observation. The population is either contaminated by other cells and these cells 
rather than MSCs, are proliferating and diluting the MSCs as passage progresses. 
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Secondly, there may be MSC subpopulations that are proliferating and dominating 
the population in later passages. If the latter explanation is the case, the 
characterization of these subpopulations may be very useful for understanding 
immunological properties of MSCs. 
 
Despite the probability of subpopulations or contaminating cell, IL6 secretion 
of MSCs regardless of subpopulations is still interesting. As mentioned above, IL6 
secretion by Kupffer cells were found to be required for initiation of liver 
regeneration after PH. This may be a potential mechanism of MSC having role in 
liver regeneration.  
 
In conclusion, we found that intravenously injected MSCs localized in livers 
of 3d post PH rat independent of their original TLR expression. Moreover, our data 
strongly suggest that it is the MSC injection that drive increase in TLR 2, 3 and 9 
expression in rats (including 1d, 3d and 5d post PH) but not the vice versa. 
 
 70
 6. FUTURE PERSPECTIVES 
  
Our studies revealed preliminary data on the timing of MSC localization 
during liver regeneration. Moreover, endogenous MSC and hepatic oval cells are 
observed after MSC administration to 3day PH rats. However, we do not know the 
factors that regulate the specific pattern of MSC localization in regenerated liver. 
Future studies to elucidate these factors (such as chemoattractant molecules) 
definitely will help to better understand liver regeneration process and provide very 
useful information for possible therapies. 
 
In order to extent our observation that MSC injection increased TLR mRNA 
expression, TLR staining of the liver sections should be studied and the tissue 
distribution of TLR proteins in response to MSC administration should be 
demonstrated. 
 
Tomchuck et al (2007) recently shown that TLR stimulation on human MSC 
drives their migration in vitro. In the light of this data, one can hypothesize that TLR 
expression profile on the MSC may contribute to homing of them through liver in 
response in PH. The TLR profile of MSC generated from normal, 1d post PH and 3d 
post PH rats can be a significant data for revealing the role of TLR in homing 
property. Moreover, these groups of MSCs may be injected to hepatectomized 
animals (with/without immunesuppressing agents) after stimulating with several 
TLR ligands. 
 
Future studies should include significant effort to elucidate the existence of 
MSC sub-populations and possibly better surface marker characterization. It would 
be fascinating to identify a subset of MSCs that do not possess TLR and drive 
immunosuppressive effect as well as another subpopulation that do express and 
induce immunostimulatory action that can cooperate with innate immune cells 
present at the local inflammatory site. 
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8. APPENDICES 
 
8.1. Appendix A 
 
Standard Solutions and Buffers 
 
Blocking Buffer (ELISA) 
500 mL 1XPBS 
25 g BSA (5%) 
250 µl Tween20 (0.025%) 
Crystal particles of BSA should be dissolved very well, with magnetic-heating stirrer 
for 20-30 minutes. The buffer should be stored at -20˚C. 
 
T-cell Buffer (ELISA) 
500 mL 1X PBS 
25 mL FBS (5%) 
250 µl Tween20 (0.025%) 
The buffer should be stored at -20˚C. 
 
Wash Buffer (ELISA) 
500 mL 10X PBS 
2.5 mL Tween20 
4.5 lt dH2O 
 
DEPC-Treated ddH2O  
1mL DEPC 
1 lt ddH2O 
Stirred in a hood for 1 hour, autoclaved in order to inactivate the DEPC 
 
10X PBS 
80 g NaCl 
2 g KCl 
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8.01 g Na2HPO4.2H2O 
2g KH2PO4 
1 liter ddH2O pH: 7.2 
Working solution (1X PBS) was prepared by diluting 10X PBS by 10 times 
 
50X TAE (Tris-Acetate-EDTA) Buffer
2M Tris Base (242 g) 
57.1 mL Glacial Acetic Acid 
50 mM EDTA 
Add to 1 lt by ddH2O  
Working solution (1X TAE) prepared by diluting 50X TAE by 50 times 
 
10X Agarose Gel Loading Dye 
0.009 g BFB 
0.009 g XC 
2.8 mL ddH2O 
1.2 mL 0.5M EDTA. 
Total volume brought to 15 mL by adding glycerol, dilute 1:10 in sample prior to 
loading to electrophoresis gel 
 
Blocking Solution for Immunofluorescent Staining 
2% BSA 
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8.2. Appendix B 
 
Photomicrograph of CM-DiI labeled MSCs before injection (4 days post 
staining in culture) 
 
(Magnification: 10X) 
 
8.3. Appendix C 
 
Fold Change in TLR2, TLR3, TLR4, TLR5, TLR6 and TLR9 expression in 
sham groups. Total RNA was recovered at different time points post PH. 
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D) 
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